Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 580 articles:
HTML format
Text format



Single Articles


    April 2017
  1. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1081-1083.
    PubMed     Text format    


    March 2017
  2. CHANG FM, Wang YP, Lang HC, Tsai CF, et al
    Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: A population-based study.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29172.
    PubMed     Text format     Abstract available


  3. SASAKI R, Devhare PB, Steele R, Ray R, et al
    Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29170.
    PubMed     Text format     Abstract available


  4. NAHON P, Seror O, Durand-Zaleski I
    Reply to: <<Screening for Hepatocellular carcinoma: A drug safety issue>>.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29174.
    PubMed     Text format    


  5. BRAILLON A
    Screening for hepatocellular carcinoma: A drug safety issue.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29173.
    PubMed     Text format    


  6. DE MATTOS AZ, Miozzo SA, Tovo CV, de Mattos AA, et al
    Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29132.
    PubMed     Text format    


  7. MOLLER S, Hove JD
    Assessment of systolic function in the evaluation of patients with cirrhosis.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29163.
    PubMed     Text format    


  8. SINCLAIR M, Schelleman A, Sandhu D, Angus PW, et al
    Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29151.
    PubMed     Text format     Abstract available


  9. YANG Y, Zhou Y, Hou J, Bai C, et al
    Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29156.
    PubMed     Text format     Abstract available


  10. HE Y, Feng D, Li M, Gao Y, et al
    Hepatic mtDNA-TLR9-microRNA-223 forms a negative feedback loop to limit neutrophil over-activation and acetaminophen hepatotoxicity.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29153.
    PubMed     Text format     Abstract available


  11. FLORIMONTE L, Iavarone M, Castellani M, Longo M, et al
    Uncommon extrahepatic metastases from hepatocellular carcinoma.
    Hepatology. 2017 Mar 10. doi: 10.1002/hep.29147.
    PubMed     Text format    


  12. WANG L, Zhang W, Ge CH, Yin RH, et al
    TLR5 signaling restrains T/NKT cell activation and protects against concanavalin A-induced hepatic injury.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29140.
    PubMed     Text format     Abstract available


  13. CAMPAGNA F, Montagnese S, Ridola L, Senzolo M, et al
    The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29146.
    PubMed     Text format     Abstract available


  14. WAN Y, Meng F, Wu N, Zhou T, et al
    Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29138.
    PubMed     Text format     Abstract available


  15. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:761-762.
    PubMed     Text format    


    February 2017
  16. FAN Z, Li L, Li M, Zhang X, et al
    The histone methyltransferase Suv39h2 contributes to non-alcoholic steatohepatitis in mice.
    Hepatology. 2017 Feb 28. doi: 10.1002/hep.29127.
    PubMed     Text format     Abstract available


  17. YAN F, Wang Y, Zhang W, Chang M, et al
    Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection.
    Hepatology. 2017 Feb 25. doi: 10.1002/hep.29134.
    PubMed     Text format     Abstract available


  18. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Reply to letter from de Mattos and colleagues: Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29131.
    PubMed     Text format    


  19. WANG W, Xu MJ, Cai Y, Zhou Z, et al
    Inflammation is independent of steatosis in a murine model of steatohepatitis.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29129.
    PubMed     Text format     Abstract available


  20. SABERI B, Dadabhai AS, Durand CM, Philosophe B, et al
    Challenges in Treatment of Hepatitis C among Patients with Hepatocellular Carcinoma.
    Hepatology. 2017 Feb 17. doi: 10.1002/hep.29126.
    PubMed     Text format    


  21. LI H, Zhou ZQ, Yang ZR, Tong DN, et al
    MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Hepatology. 2017 Feb 14. doi: 10.1002/hep.29116.
    PubMed     Text format     Abstract available


  22. LEMPP FA, Wiedtke E, Qu B, Roques P, et al
    Sodium taurocholate cotransporting polypeptide is the limiting host factor of Hepatitis B Virus infection in macaque and pig hepatocytes.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29112.
    PubMed     Text format     Abstract available


  23. BRUDEN DJ, McMahon BJ, Townshend-Bulson L, Gounder P, et al
    Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29115.
    PubMed     Text format     Abstract available


  24. WANG H, An P, Xie E, Wu Q, et al
    Characterization of Ferroptosis in Murine Models of Hemochromatosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29117.
    PubMed     Text format     Abstract available


  25. GOLDEN-MASON L, Rosen HR
    Galectin-9: Diverse Roles in Hepatic Immune Homeostasis and Inflammation.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29106.
    PubMed     Text format     Abstract available


  26. IWAKIRI Y
    Reply to the Letter to the Editor in regards to the commentary on "The lymphatic system: A new frontier in hepatology".
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29102.
    PubMed     Text format    


  27. YOTTI R, Ripoll C, Benito Y, Catalina MV, et al
    Left ventricular systolic function is associated to sympathetic nervous activity and markers of inflammation in cirrhosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29104.
    PubMed     Text format     Abstract available


  28. GOLDSWORTHY MA, Rowe IA
    Patient understanding of hepatocellular carcinoma surveillance.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29103.
    PubMed     Text format    


  29. KUMAR A, Davuluri G, deSilva RN, Engelen MP, et al
    Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29107.
    PubMed     Text format    


  30. KRAWCZYK M, Rau M, Grunhage F, Schattenberg JM, et al
    The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29100.
    PubMed     Text format    


  31. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available


  32. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


  33. FERNANDEZ CARRILLO C, Lens S, Llop E, Pascasio JM, et al
    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29097.
    PubMed     Text format     Abstract available


  34. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:399-400.
    PubMed     Text format    


    January 2017
  35. VILASECA M, Garcia-Caldero H, Lafoz E, Garcia-Irigoyen O, et al
    The anticoagulant Rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
    Hepatology. 2017 Jan 31. doi: 10.1002/hep.29084.
    PubMed     Text format     Abstract available


  36. WANG Y, Vincent R, Yang J, Asgharpour A, et al
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29090.
    PubMed     Text format     Abstract available


  37. VON LOEFFELHOLZ C, Lieske S, Neuschafer-Rube F, Willmes DM, et al
    The Human Longevity Gene Homolog INDY and Interleukin-6 Interact in Hepatic Lipid Metabolism.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29089.
    PubMed     Text format     Abstract available


  38. GORDON-WEEKS AN, Lim SY, Yuzhalin AE, Jones K, et al
    Neutrophils Promote Hepatic Metastasis Growth Through fibroblast growth factor (FGF)2-dependent Angiogenesis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29088.
    PubMed     Text format     Abstract available


  39. HEIMBACH J, Kulik LM, Finn R, Sirlin CB, et al
    Aasld guidelines for the treatment of hepatocellular carcinoma.
    Hepatology. 2017 Jan 28. doi: 10.1002/hep.29086.
    PubMed     Text format    


  40. SHIMIZU Y, Peltzer N, Sevko A, Lafont E, et al
    The linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29074.
    PubMed     Text format     Abstract available


  41. HARGROVE L, Kennedy L, Demieville J, Jones H, et al
    BDL-induced biliary hyperplasia, hepatic injury and fibrosis are reduced in mast cell deficient Kitw-sh mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29079.
    PubMed     Text format     Abstract available


  42. STEINMETZ C, Kashyap A, Zhivkova N, Alizor H, et al
    Activation of SIRT1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammation.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29072.
    PubMed     Text format     Abstract available


  43. SABATE A, Blasi A
    Thromboelastography and blood product usage in cirrhosis with severe coagulopathy.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29061.
    PubMed     Text format    


  44. VILLANUEVA C, Graupera I, Aracil C, Alvarado E, et al
    A Randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29056.
    PubMed     Text format     Abstract available


  45. DRIVER R, Rowe IA
    What is the benefit of early follow-up after hospitalization for patients with cirrhosis?
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29060.
    PubMed     Text format    


  46. JOO EJ, Chang Y, Ryu S
    Response to NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29048.
    PubMed     Text format    


  47. LONARDO A, Nascimbeni F, Ballestri S
    NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29052.
    PubMed     Text format    


  48. LIN L, Ding Y, Wang Y, Wang Z, et al
    Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29033.
    PubMed     Text format     Abstract available


  49. ATANASOVSKA B, Rensen SS, van der Sijde MR, Marsman G, et al
    A liver-specific long non-coding RNA with a role in cell viability is elevated in human non-alcoholic steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29034.
    PubMed     Text format     Abstract available


  50. JANG JE, Park HS, Yoo HJ, Baek IJ, et al
    Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29039.
    PubMed     Text format     Abstract available


  51. LEFERE S, Hoorens A, Raevens S, Troisi R, et al
    Refractory subacute steatohepatitis after biliopancreatic diversion.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29038.
    PubMed     Text format     Abstract available


  52. BRUSCHI FV, Claudel T, Tardelli M, Caligiuri A, et al
    The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29041.
    PubMed     Text format     Abstract available


  53. PASTORE N, Attanasio S, Granese B, Teckman J, et al
    Activation of JNK pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29035.
    PubMed     Text format     Abstract available


  54. YUE X, Ai J, Xu Y, Chen Y, et al
    Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29036.
    PubMed     Text format     Abstract available


  55. ALKHOURI N, Feldstein AE
    Treating Nonalcoholic Steatohepatitis (NASH) in Children: Not a Cinch Task.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29043.
    PubMed     Text format     Abstract available


  56. STRAZZABOSCO M, Allen JI, Teisberg EO
    Value based care in hepatology.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29042.
    PubMed     Text format     Abstract available


  57. VARRASSO G, Schiavetti A, Lanciotti S, Sapio M, et al
    Propranolol as First Line Treatment for Life-threatening Diffuse Infantile Hepatic Hemangioma: A Case Report.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29028.
    PubMed     Text format    


  58. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1-3.
    PubMed     Text format    


    December 2016
  59. SHUNG DL, Garcia-Tsao G
    Liver Capsule: Portal Hypertension and Varices: Pathogenesis, Stages and Management.
    Hepatology. 2016 Dec 29. doi: 10.1002/hep.29026.
    PubMed     Text format    


  60. LI N, Zhou ZS, Shen Y, Xu J, et al
    Inhibition of the SREBP pathway suppresses hepatocellular carcinoma through repressing inflammation.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29018.
    PubMed     Text format     Abstract available


  61. MCCOMMIS KS, Hodges WT, Brunt EM, Nalbantoglu I, et al
    Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29025.
    PubMed     Text format     Abstract available


  62. LI D, Liu X, Zhou J, Hu J, et al
    LncRNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of ERK and YB-1 to enhance hepatocarcinogenesis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29010.
    PubMed     Text format     Abstract available


  63. TANDON P, Raman M, Mourtzakis M, Merli M, et al
    A Practical Approach to Nutritional Screening and Assessment in Cirrhosis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29003.
    PubMed     Text format     Abstract available


  64. HAUSSINGER D, Keitel V
    Dual role of the bile acid receptor TGR5 for hepatic lipid metabolism in feast and famine.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29017.
    PubMed     Text format    


  65. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  66. AYUBI E, Safiri S, Sani M, Doosti-Irani A, et al
    Effect of Metabolic syndrome on cardiovascular, hepatic events and death in CHB patients: Methodological issues.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.29001.
    PubMed     Text format    


  67. BERZIGOTTI A, Albillos A, Villanueva C, Genesca J, et al
    Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28992.
    PubMed     Text format     Abstract available


  68. MICHALOPOULOS GK
    Hepatostat: Liver regeneration and normal liver tissue maintenance.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28988.
    PubMed     Text format     Abstract available


  69. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  70. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


  71. MORIS D, Felekouras E
    Ignore reality but not the consequences of its ignorance: Broaden Guidelines in surgery of Hepatocellular carcinoma.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28984.
    PubMed     Text format     Abstract available


  72. TAO J, Zhang R, Singh S, Poddar M, et al
    Targeting beta-catenin in hepatocellular cancers induced by co-expression of mutant beta-catenin and K-Ras in mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28975.
    PubMed     Text format     Abstract available


  73. BRIL F, Barb D, Portillo-Sanchez P, Biernacki D, et al
    Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28985.
    PubMed     Text format     Abstract available


  74. MORZYGLOD L, Cauzac M, Popineau L, Denechaud PD, et al
    Grb14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28972.
    PubMed     Text format     Abstract available


  75. YAN FJ, Zhang XJ, Wang WX, Ji YX, et al
    The E3 ligase TRIM8 targets TAK1 to promote insulin resistance and steatohepatitis.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28971.
    PubMed     Text format     Abstract available


  76. KAFFE E, Katsifa A, Xylourgidis N, Ninou I, et al
    Hepatocyte Autotaxin expression promotes liver fibrosis and cancer.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28973.
    PubMed     Text format     Abstract available


  77. BUSCH CJ, Hendrikx T, Weismann D, Jackel S, et al
    Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28970.
    PubMed     Text format     Abstract available


  78. FAN W, Yang H, Liu T, Wang J, et al
    Prohibitin 1 Suppresses Liver Cancers Tumorigenesis in Mice and Human Hepatocellular and Cholangiocarcinoma cells.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28964.
    PubMed     Text format     Abstract available


  79. PRICE JC, Ma Y, Scherzer R, Korn N, et al
    HIV-infected and Uninfected Adults with Non-Genotype 3 Hepatitis C Virus Have Less Hepatic Steatosis than Adults with Neither Infection.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28968.
    PubMed     Text format     Abstract available


  80. TAHARA Y, Shibata S
    Abnormal tuning of the hepatic circadian metabolic rhythms in lung cancer.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28982.
    PubMed     Text format    


  81. HERNAEZ R, El-Serag H, DeBakey ME
    Hepatocellular Carcinoma Surveillance: The Road Ahead.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28983.
    PubMed     Text format    



  82. 2016 Hepatology referees (volumes 63 and 64).
    Hepatology. 2016;64:2280-2285.
    PubMed     Text format    


  83. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1829-1830.
    PubMed     Text format    


    November 2016
  84. VALDECANTOS MP, Pardo V, Ruiz L, Castro-Sanchez L, et al
    A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28962.
    PubMed     Text format     Abstract available


  85. KLEBANOFF MJ, Corey KE, Chhatwal J, Kaplan LM, et al
    Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28958.
    PubMed     Text format     Abstract available


  86. TRAN M, Wang L
    Preserving LXR by Inhibiting T39: A step closer to treating atherosclerosis and steatohepatitis?
    Hepatology. 2016 Nov 17. doi: 10.1002/hep.28946.
    PubMed     Text format    


  87. ASKGAARD G, Leon DA, Kjaer MS, Deleuran T, et al
    Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study.
    Hepatology. 2016 Nov 16. doi: 10.1002/hep.28943.
    PubMed     Text format     Abstract available


  88. NEWBERRY EP, Xie Y, Kennedy SM, Graham MJ, et al
    Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in Liver fatty acid binding protein null mice.
    Hepatology. 2016 Nov 14. doi: 10.1002/hep.28941.
    PubMed     Text format     Abstract available


  89. VAN ASTEN M, Verhaegh P, Koek G, Verbeek J, et al
    The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.
    Hepatology. 2016 Nov 10. doi: 10.1002/hep.28940.
    PubMed     Text format    


  90. CALDWELL S, Lisman T
    The cirrhotic platelet: Shedding light on an enigma.
    Hepatology. 2016 Nov 7. doi: 10.1002/hep.28931.
    PubMed     Text format    


  91. KIM JH, Sinn DH, Kang W, Gwak GY, et al
    Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28916.
    PubMed     Text format     Abstract available


  92. YAN S, Tang J, Zhang Y, Wang Y, et al
    Prostaglandin E2 promotes hepatic bile acid synthesis by an E prostanoid receptor 3-mediated hepatocyte nuclear receptor 4alpha/cholesterol 7alpha-hydroxylase pathway in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28928.
    PubMed     Text format     Abstract available


  93. MASSEY VL, Dolin CE, Poole LG, Hudson SV, et al
    The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28918.
    PubMed     Text format     Abstract available


  94. NIU Y, Xu M, Slagle BL, Huang H, et al
    Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28924.
    PubMed     Text format     Abstract available


  95. DESBOROUGH MJ, Kahan BC, Stanworth SJ, Jairath V, et al
    Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28915.
    PubMed     Text format    


  96. DROLZ A, Fuhrmann V
    "Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding".
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28914.
    PubMed     Text format    


  97. CAI WY, Lin LY, Hao H, Zhang SM, et al
    YAP-TEAD and HNF4alpha repress reciprocally to regulate hepatocarcinogenesis.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28911.
    PubMed     Text format     Abstract available


  98. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1395-1397.
    PubMed     Text format    


  99. QURESHI MA, Kim YO, Schuppan D
    Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression.
    Hepatology. 2016;64:1794-1797.
    PubMed     Text format    


  100. TAO J, Xu E, Zhao Y, Singh S, et al
    Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin.
    Hepatology. 2016;64:1587-1605.
    PubMed     Text format     Abstract available


    October 2016
  101. GARCIA-TSAO G, Abraldes J, Berzigotti A, Bosch J, et al
    Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis and Management - 2016 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2016 Oct 27. doi: 10.1002/hep.28906.
    PubMed     Text format    


  102. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Text format     Abstract available


  103. TANDON P, Reddy KR, O'Leary JG, Garcia-Tsao G, et al
    A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28900.
    PubMed     Text format     Abstract available


  104. ATIQ O, Tiro J, Yopp AC, Muffler A, et al
    An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28895.
    PubMed     Text format     Abstract available


  105. SUMAZIN P, Chen Y, Trevino LR, Sarabia SF, et al
    Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28888.
    PubMed     Text format     Abstract available


  106. KIMER N, Pedersen JS, Busk TM, Gluud LL, et al
    Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28898.
    PubMed     Text format     Abstract available


  107. SUN Q, Loughran P, Shapiro R, Shrivastava IH, et al
    Redox-dependent regulation of hepatocyte AIM2 inflammasome activation in sterile liver injury in mice.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28893.
    PubMed     Text format     Abstract available


  108. KE S, Chen S, Dong Z, Hong CS, et al
    Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28889.
    PubMed     Text format     Abstract available


  109. LABONTE AC, Sung SJ, Jennelle LT, Dandekar AP, et al
    Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28873.
    PubMed     Text format     Abstract available


  110. PARIKH ND, Marshall VD, Singal AG, Nathan H, et al
    Survival and Cost-Effectiveness of Sorafenib Therapy in Advanced Hepatocellular Carcinoma: An Analysis of the SEER-Medicare Database.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28881.
    PubMed     Text format     Abstract available


  111. GARCIA-TSAO G
    Empowering Women - Perspective from a Hepatologist.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28875.
    PubMed     Text format    


  112. BERGMANN J, Muller M, Baumann N, Reichert M, et al
    IL-6 trans-signaling is essential for the development of hepatocellular carcinoma.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28874.
    PubMed     Text format     Abstract available


  113. MAROT A, Vandenbulcke H, Knebel JF, Doerig C, et al
    External validation of the nomogram for individualized prediction of HCC occurrence in patients with HCV-related compensated cirrhosis.
    Hepatology. 2016 Oct 13. doi: 10.1002/hep.28865.
    PubMed     Text format    


  114. HASLAM DB
    Non-alcoholic steatohepatitis and the intestinal microbiota.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28864.
    PubMed     Text format    


  115. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1011-3.
    PubMed     Text format    


    September 2016
  116. ALI KHAN M, Cholankeril G, Howden CW
    Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.
    Hepatology. 2016 Sep 30. doi: 10.1002/hep.28858.
    PubMed     Text format    


  117. LAINE F, Ruivard M, Loustaud-Ratti V, Bonnet F, et al
    Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28856.
    PubMed     Text format     Abstract available


  118. CHENG JY, Wong VW, Tse YK, Chim AM, et al
    Metabolic syndrome increases cardiovascular event but not hepatic event and death in patients with chronic hepatitis B.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28778.
    PubMed     Text format     Abstract available


  119. PONZETTO A, Srinivasan RS
    Risk factors for hepatocellular carcinoma.
    Hepatology. 2016 Sep 28. doi: 10.1002/hep.28854.
    PubMed     Text format    


  120. LO GH
    The risk of bleeding after invasive procedures in cirrhotics with severe coagulopathy.
    Hepatology. 2016 Sep 26. doi: 10.1002/hep.28855.
    PubMed     Text format    


  121. CUSI K
    Nonalcoholic Steatohepatitis in Non-Obese Patients: Not So Different After All.
    Hepatology. 2016 Sep 20. doi: 10.1002/hep.28839.
    PubMed     Text format    


  122. RAPARELLI V, Basili S, Carnevale R, Napoleone L, et al
    Low-grade endotoxemia and platelet activation in cirrhosis.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28853.
    PubMed     Text format     Abstract available


  123. LI D, Li W, Hui L
    Hybrid hepatocyte: A newly identified player for regeneration in hepatic injuries.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28837.
    PubMed     Text format     Abstract available


  124. MULLIGAN DC
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.
    PubMed     Text format    


  125. AMARAPURKAR D, Somani V, Shah A
    Do we need to correct coagulation abnormalities prophylactically in cirrhotics undergoing invasive procedures? - A Dilemma.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28830.
    PubMed     Text format    


  126. EGUCHI A, Lazaro RG, Wang J, Kim J, et al
    Extracellular vesicles released by hepatocytes from gastric infusion model of ALD contain a miRNA barcode that can be detected in blood.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28838.
    PubMed     Text format     Abstract available


  127. GASTALDELLI A, Gaggini M, Daniele G, Ciociaro D, et al
    Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic PET study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28827.
    PubMed     Text format     Abstract available


  128. ABRALDES JG, Bureau C, Stefanescu H, Augustin S, et al
    Non-invasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28824.
    PubMed     Text format     Abstract available


  129. AZZARITI A, Mancarella S, Porcelli L, Elisa Quatrale A, et al
    Hepatic Stellate Cells Induce HCC Cell Resistance to Sorafenib through the Laminin-332/alpha3 Integrin Axis recovery of FAK Ubiquitination.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28835.
    PubMed     Text format     Abstract available


  130. TANAKA S, Hikita H, Tatsumi T, Sakamori R, et al
    Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease.
    Hepatology. 2016 Sep 16. doi: 10.1002/hep.28820.
    PubMed     Text format     Abstract available


  131. KAMINSKY P, Preiss J, Sasatomi E, Gerber DA, et al
    Biliary Adenofibroma: A Rare Hepatic Lesion with Malignant Features.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28818.
    PubMed     Text format    


  132. RUSSO MW, Koteish A, Fuchs M, Reddy G, et al
    Workforce in Hepatology: Update and a critical need for more information.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28810.
    PubMed     Text format     Abstract available


  133. HO CM, Chen HL
    Expression of Glutamine Synthetase in Hepatocyte Progenitor Cells Derived from Canal of Hering.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28805.
    PubMed     Text format    


  134. TREVISANI F, Bucci L, Garuti F
    Is it time to extend criteria for hepatic resection in the treatment of hepatocellular carcinoma?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28804.
    PubMed     Text format    


  135. SOLINAS A, Calvisi DF
    PD-L1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28803.
    PubMed     Text format    


  136. RENOU C, Lesgourgues B, Macaigne G, Pauwels A, et al
    Hepatitis E in decompensated alcoholic cirrhosis.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28792.
    PubMed     Text format    


  137. PASCALE RM, Feo F, Calvisi DF
    An infernal crosstalk between oncogenic beta-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling.
    Hepatology. 2016 Sep 6. doi: 10.1002/hep.28790.
    PubMed     Text format    


  138. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:703-5.
    PubMed     Text format    


    August 2016
  139. TORNER A, Stokkeland K, Svensson A, Dickman PW, et al
    The underreporting of hepatocellular carcinoma to the Cancer Register and a log-linear model to estimate a more correct incidence.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28775.
    PubMed     Text format     Abstract available


  140. OKABE H, Yang J, Sylakowski K, Yovchev M, et al
    Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28774.
    PubMed     Text format     Abstract available


  141. LAUSCHKE VM, Vorrink SU, Moro SM, Reyazee F, et al
    Massive rearrangements of cellular miRNA signatures are key drivers of hepatocyte dedifferentiation.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28780.
    PubMed     Text format     Abstract available


  142. LALEMAN W, Trebicka J, Verbeke L
    Evolving insights in the pathophysiology of complications of cirrhosis: The Farnesoid-X receptor (FXR) to the rescue?
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28771.
    PubMed     Text format    


  143. FARVARDIN S, Patel J, Khambaty M, Yerokun OA, et al
    Patient-Reported Barriers are Associated with Lower HCC Surveillance Rates in Patients with Cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28770.
    PubMed     Text format     Abstract available


  144. SALLOUM S, Holmes JA, Jindal R, Bale SS, et al
    HIV/HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28766.
    PubMed     Text format     Abstract available


  145. GOLDBERG DS, Taddei TH, Serper M, Mehta R, et al
    Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28765.
    PubMed     Text format     Abstract available


  146. CHEN HA, Kuo TC, Tseng CF, Ma JT, et al
    ANGPTL1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma Cells.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28773.
    PubMed     Text format     Abstract available


  147. CLERBAUX LA, Manco R, Leclercq I
    Upstream regulators of hepatic Wnt/beta-catenin activity control liver metabolic zonation, development and regeneration.
    Hepatology. 2016 Aug 12. doi: 10.1002/hep.28763.
    PubMed     Text format    


  148. MIKOLAJCZYK AE, Farnan JM, McConville JF, Jensen DM, et al
    Novel Educational Interventions in Residency Increase Knowledge of Chronic Liver Disease and Career Interest in Hepatology.
    Hepatology. 2016 Aug 10. doi: 10.1002/hep.28741.
    PubMed     Text format     Abstract available


  149. BIHARI C, Anand L, Rooge S, Kumar D, et al
    Bone Marrow Stem Cells and its Niche Components are Adversely Affected in Advanced Cirrhosis of Liver.
    Hepatology. 2016 Aug 3. doi: 10.1002/hep.28754.
    PubMed     Text format     Abstract available


  150. CLARIA J, Stauber RE, Coenraad MJ, Moreau R, et al
    systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28740.
    PubMed     Text format     Abstract available


  151. DROLZ A, Fuhrmann V
    Reply to "Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis".
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28757.
    PubMed     Text format    


  152. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


  153. HU W, Zhang W, Chen Y, Rana U, et al
    Nogo-B receptor deficiency increases LXRalpha nuclear translocation and hepatic lipogenesis via an AMPKalpha-dependent pathway.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28747.
    PubMed     Text format     Abstract available



  154. Correction: Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes.
    Hepatology. 2016;64:702.
    PubMed     Text format    


  155. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:325-7.
    PubMed     Text format    


    July 2016
  156. QI X, De Stefano V, Guo X
    Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28743.
    PubMed     Text format    


  157. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Proton Pump Inhibitors as a Risk Factor for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Cirrhosis Patients With Ascites.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28737.
    PubMed     Text format     Abstract available


  158. LI L, Piontek K, Ishida M, Fausther M, et al
    Extracellular vesicles carry miR-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28735.
    PubMed     Text format     Abstract available


  159. MAROT A, Trepo E, Doerig C, Moreno C, et al
    SEMS should be considered in patients with cirrhosis and uncontrolled variceal bleeding.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28738.
    PubMed     Text format    


  160. DUNCAN SA
    Multipotent stem cells and their lineage restriction to hepatocytes.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28727.
    PubMed     Text format    


  161. SUGIYAMA M, Kanto T
    Dual blockade of HCV entry at a gatekeeper of hepatocytes - Not only a preventive but also therapeutic target of CLDN-1.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28726.
    PubMed     Text format    


  162. PORAT-SHLIOM N, Tietgens AJ, Van Itallie CM, Vitale-Cross L, et al
    Liver Kinase B1 regulates hepatocellular tight junction distribution and function in vivo.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28724.
    PubMed     Text format     Abstract available


  163. KOPPE C, Verheugd P, Gautheron J, Reisinger F, et al
    IKKalpha/beta control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator RIPK1.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28723.
    PubMed     Text format     Abstract available


  164. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.
    PubMed     Text format    


  165. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1-3.
    PubMed     Text format    


    June 2016
  166. CUERVO H, Nielsen CM, Simonetto DA, Ferrell L, et al
    Endothelial Notch signaling is essential to prevent hepatic vascular malformations in mice.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28713.
    PubMed     Text format     Abstract available


  167. CALDERARO J, Rousseau B, Amaddeo G, Mercey M, et al
    PD-L1 expression in hepatocellular carcinoma: Relationship with clinical and pathological features.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28710.
    PubMed     Text format     Abstract available


  168. WU D, Liu G, Liu Y, Saiyin H, et al
    Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis via discs large 1-mediated yes associated protein inactivation.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28708.
    PubMed     Text format     Abstract available


  169. DONEPUDI AC, Boehme S, Li F, Chiang JY, et al
    G protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis.
    Hepatology. 2016 Jun 28. doi: 10.1002/hep.28707.
    PubMed     Text format     Abstract available


  170. KALAMBOKIS GN, Oikonomou A, Christou L, Baltayiannis G, et al
    High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis.
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28703.
    PubMed     Text format    


  171. GANNE-CARRIE N, Layese R, Bourcier V, Cagnot C, et al
    Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28702.
    PubMed     Text format     Abstract available


  172. HANNAH WN JR, Harrison SA
    Non-invasive Imaging Methods to Determine Severity of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Jun 24. doi: 10.1002/hep.28699.
    PubMed     Text format     Abstract available


  173. KANG DJ, Betrapally NS, Ghosh SA, Sartor RB, et al
    Gut microbiota drive the development of neuro-inflammatory response in cirrhosis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28696.
    PubMed     Text format     Abstract available


  174. SUK KT, Yoon JH, Kim MY, Kim CW, et al
    Transplantation with Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28693.
    PubMed     Text format     Abstract available


  175. ZHANG H, Xing Z, Mani SK, Bancel B, et al
    RNA helicase DDX5 regulates PRC2/HOTAIR function in Hepatitis B Virus infection and hepatocarcinogenesis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28698.
    PubMed     Text format     Abstract available


  176. CUI J, Chen CH, Lo MT, Schork N, et al
    Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.
    Hepatology. 2016 Jun 17. doi: 10.1002/hep.28674.
    PubMed     Text format     Abstract available


  177. DI PASCOLI M, Zampieri F, Verardo A, Pesce P, et al
    Inhibition of EETs production in cirrhotic rats has beneficial effects on portal hypertension by reducing splanchnic vasodilation.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28686.
    PubMed     Text format     Abstract available


  178. THOMSEN MK, Nandakumar R, Stadler D, Malo A, et al
    Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28685.
    PubMed     Text format     Abstract available


  179. PLOEGER C, Waldburger N, Fraas A, Goeppert B, et al
    Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28684.
    PubMed     Text format     Abstract available


  180. SETIAWAN VW, Stram DO, Porcel J, Lu SC, et al
    Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The Multiethnic Cohort.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28677.
    PubMed     Text format     Abstract available


  181. MARQUARDT JU
    Deconvolution of the cellular origin in hepatocellular carcinoma - hepatocytes take the center stage.
    Hepatology. 2016 Jun 10. doi: 10.1002/hep.28671.
    PubMed     Text format    


  182. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1749-1751.
    PubMed     Text format    


    May 2016
  183. INZAUGARAT ME, Wree A, Feldstein AE
    Hepatocyte mitochondrial DNA released in microparticles and TLR9 activation: A link between lipotoxicity and inflammation during NASH.
    Hepatology. 2016 May 30. doi: 10.1002/hep.28666.
    PubMed     Text format    


  184. CHIU DK, Xu IM, Lai RK, Tse AP, et al
    Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28655.
    PubMed     Text format     Abstract available


  185. SUNG FY, Lan CY, Huang CJ, Lin CL, et al
    Progressive accumulation of mutations in the hepatitis B virus genome and its impact for time to diagnosis of hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28654.
    PubMed     Text format     Abstract available


  186. ZEISEL MB, Baumert TF
    Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28653.
    PubMed     Text format    


  187. IWAKIRI Y
    The Lymphatic system: A new frontier in hepatology.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28650.
    PubMed     Text format    


  188. MATSUURA K, De Giorgi V, Schechterly C, Wang RY, et al
    Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28660.
    PubMed     Text format     Abstract available


  189. LEE SA, Yuen JJ, Jiang H, Kahn BB, et al
    Adipocyte-specific over-expression of retinol-binding protein 4 (RBP4) causes hepatic steatosis in mice.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28659.
    PubMed     Text format     Abstract available


  190. ZOU Y, Li G, Wang L
    Colony-stimulating factor 1 should be considered when studying the miR-28-5p-IL-34-macrophage feedback loop in hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28658.
    PubMed     Text format    


  191. HAPPERTS S, Foucault A, Billiard JS, Nguyen B, et al
    Combined hepatocellular-cholangiocarcinoma in a patient with Abernethy malformation and Tetralogy of Fallot - A case report.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28656.
    PubMed     Text format    


  192. PIANO S, Angeli P
    Terlipressin administration for type 1 hepatorenal syndrome. More answers than open questions.
    Hepatology. 2016 May 17. doi: 10.1002/hep.28648.
    PubMed     Text format    


  193. HEWETT LJ, Bradshaw ML, Gordon LL, Rockey DC, et al
    Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28634.
    PubMed     Text format    


  194. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


  195. WAN ZY, Tian JS, Tan HW, Chow AL, et al
    Mechanistic target of rapamycin complex 1 (mTORC1) is an essential mediator of metabolic and mitogenic effects of FGF19 in hepatoma cells.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28639.
    PubMed     Text format     Abstract available


  196. LI D, Fu J, Du M, Zhang H, et al
    Hepatocellular carcinoma repression by TNFalpha-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28637.
    PubMed     Text format     Abstract available


  197. LIU M, Chen L, Ma NF, Chow RK, et al
    CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
    Hepatology. 2016;63:1544-1559.
    PubMed     Text format     Abstract available


  198. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1405-1407.
    PubMed     Text format    


  199. VALANEJAD L, Timchenko N
    Akt-FoxO1 axis controls liver regeneration.
    Hepatology. 2016;63:1424-6.
    PubMed     Text format    


  200. BEZERRA JA
    MDR3 mutation analysis: A step closer to precision medicine.
    Hepatology. 2016;63:1421-3.
    PubMed     Text format    


  201. BLOKS VW, Plosch T, Jonker JW, Kuipers F, et al
    Reply to: "Impaired expression of multidrug resistance-associated protein 2 and liver damage in erythropoietic protoporphyria".
    Hepatology. 2016;63:1743-4.
    PubMed     Text format    


  202. SCHWIMMER JB
    Clinical advances in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1718-25.
    PubMed     Text format    


  203. LIASKOU E, Klemsdal Henriksen EK, Holm K, Kaveh F, et al
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.
    Hepatology. 2016;63:1608-19.
    PubMed     Text format     Abstract available


    April 2016
  204. DROLZ A, Horvatits T, Roedl K, Rutter K, et al
    Coagulation parameters and major bleeding in critically ill patients with cirrhosis.
    Hepatology. 2016 Apr 28. doi: 10.1002/hep.28628.
    PubMed     Text format     Abstract available


  205. HSIN IF, Montano E, Seki E
    Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1.
    Hepatology. 2016 Apr 27. doi: 10.1002/hep.28627.
    PubMed     Text format    


  206. TANG H, Bai HX, Su C, Lee AM, et al
    The effect of cirrhosis on radiogenomic biomarker's ability to predict microvascular invasion and outcome in hepatocellular carcinoma.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28620.
    PubMed     Text format    


  207. MALIZIA G, Cervello OV, D'Amico G
    Statins in cirrhosis: The magic pill?
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28616.
    PubMed     Text format    


  208. SHIN S, Wangensteen KJ, Teta-Bissett M, Wang YJ, et al
    Genetic Lineage Tracing Analysis of the Cell of Origin of Hepatotoxin-Induced Liver Tumors in Mice.
    Hepatology. 2016 Apr 21. doi: 10.1002/hep.28602.
    PubMed     Text format     Abstract available


  209. CHENG AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, et al
    Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28600.
    PubMed     Text format     Abstract available


  210. GLUUD LL, Vilstrup H, Morgan MY
    Non-Absorbable Disaccharides for Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28598.
    PubMed     Text format     Abstract available


  211. ARRIVE L, Zucman-Rossi J, Balladur P, Wendum D, et al
    Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis.
    Hepatology. 2016 Apr 4. doi: 10.1002/hep.28590.
    PubMed     Text format    



  212. Correction: Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Hepatology. 2016;63:1403.
    PubMed     Text format    


  213. CUBERO FJ
    Shutting off inflammation: A novel switch on hepatic stellate cells.
    Hepatology. 2016;63:1086-9.
    PubMed     Text format    


  214. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1065-7.
    PubMed     Text format    


  215. MOLLER S
    Toward new standards for noninvasive measuring of portal pressure?
    Hepatology. 2016;63:1384-6.
    PubMed     Text format    


  216. VINCIGUERRA M, Mazzoccoli G
    Aryl hydrocarbon receptor-fibroblast growth factor 21 dissociation of fatty liver from insulin resistance: A timely matter?
    Hepatology. 2016;63:1396-7.
    PubMed     Text format    


  217. LU P, Xie W
    Reply.
    Hepatology. 2016;63:1397-8.
    PubMed     Text format    


  218. STEFANESCU H, Lupsor-Platon M, Badea RI
    The devil's triangle of steatosis, obesity, and liver stiffness.
    Hepatology. 2016;63:1392-3.
    PubMed     Text format    


  219. PETTA S, Craxi A
    Reply.
    Hepatology. 2016;63:1394.
    PubMed     Text format    


  220. TAPPER EB, Lai M
    Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study.
    Hepatology. 2016;63:1184-9.
    PubMed     Text format     Abstract available


  221. UNALP-ARIDA A, Ruhl CE
    Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Hepatology. 2016;63:1170-83.
    PubMed     Text format     Abstract available


  222. GUAL P, Postic C
    Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1074-7.
    PubMed     Text format    


  223. THORGEIRSSON SS
    Stemness and reprogramming in liver cancer.
    Hepatology. 2016;63:1068-70.
    PubMed     Text format    


  224. GARIANI K, Menzies KJ, Ryu D, Wegner CJ, et al
    Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
    Hepatology. 2016;63:1190-204.
    PubMed     Text format     Abstract available


  225. SHNEIDER BL, de Ville de Goyet J, Leung DH, Srivastava A, et al
    Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium.
    Hepatology. 2016;63:1368-80.
    PubMed     Text format     Abstract available


  226. PIANO S, Fasolato S, Salinas F, Romano A, et al
    The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Hepatology. 2016;63:1299-309.
    PubMed     Text format     Abstract available


    March 2016
  227. SERLIE MJ, Ter Horst KW, Brown AW
    Addendum: Hypercaloric diets with high meal frequency, but not increased meal size, increase intrahepatic triglycerides: A randomized controlled trial.
    Hepatology. 2016 Mar 31. doi: 10.1002/hep.28588.
    PubMed     Text format    


  228. KAI AK, Chan LK, Lo RC, Lee JM, et al
    Downregulation of TIMP2 via HIF-1alpha/miR-210/HIF-3alpha regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
    Hepatology. 2016 Mar 28. doi: 10.1002/hep.28577.
    PubMed     Text format     Abstract available


  229. KALAMBOKIS GN, Christodoulou D, Baltayiannis G, Christou L, et al
    Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites.
    Hepatology. 2016 Mar 26. doi: 10.1002/hep.28575.
    PubMed     Text format    


  230. ARAB JP, Shah VH
    Statins and portal hypertension: A tale of two models.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28567.
    PubMed     Text format    


  231. REZVANI M, Grimm A, Willenbring H
    Assessing the Therapeutic Potential of Lab-Made Hepatocytes.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28569.
    PubMed     Text format     Abstract available


  232. MARRONE J, Soria LR, Danielli M, Lehmann GL, et al
    Hepatic Gene Transfer of Human Aquaporin-1 Improves Bile Salt Secretory Failure in Rats with Estrogen-Induced Cholestasis.
    Hepatology. 2016 Mar 21. doi: 10.1002/hep.28564.
    PubMed     Text format     Abstract available


  233. KANWAL F, Asch SM, Kramer JR, Cao Y, et al
    Early Outpatient Follow-up and 30-day Outcomes in Patients Hospitalized with Cirrhosis.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28558.
    PubMed     Text format     Abstract available


  234. RAO Q, Zuo B, Lu Z, Gao X, et al
    Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and human in vitro.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28549.
    PubMed     Text format     Abstract available


  235. TAKASHIMA Y, Terada M, Udono M, Miura S, et al
    Suppression of let-7b and miR-125a/b maturation by Lin28b enables maintenance of stem cell properties in hepatoblasts.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28548.
    PubMed     Text format     Abstract available


  236. BISSONNETTE J, Garcia-Pagan JC, Albillos A, Turon F, et al
    Role of the Transjugular Intrahepatic Portosystemic Shunt in the Management of Severe Complications of Portal Hypertension in Idiopathic Noncirrhotic Portal Hypertension.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28547.
    PubMed     Text format     Abstract available


  237. TREVISANI F, Golfieri R
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: Where are we now?
    Hepatology. 2016 Mar 16. doi: 10.1002/hep.28554.
    PubMed     Text format    


  238. MCPHAIL MJ, Auzinger G, Bernal W, Wendon JA, et al
    Decisions on futility in patients with cirrhosis and organ failure.
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28539.
    PubMed     Text format    


  239. GUSTOT T, Fernandez J, Pavesi M, Arroyo V, et al
    Reply to "Decisions on futility in patients with cirrhosis and organ failure".
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28538.
    PubMed     Text format    


  240. ABRALDES JG, Burak KW
    STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28537.
    PubMed     Text format    


  241. EL-SERAG HB, Kanwal F, Richardson P, Kramer J, et al
    Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection.
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28535.
    PubMed     Text format     Abstract available



  242. Correction: Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Hepatology. 2016;63:1064.
    PubMed     Text format    



  243. Correction: Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition via Akt/GSK-3beta/snail signaling.
    Hepatology. 2016;63:1064.
    PubMed     Text format    


  244. SAMARIN J, Laketa V, Malz M, Roessler S, et al
    PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
    Hepatology. 2016;63:813-26.
    PubMed     Text format     Abstract available


  245. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:679-81.
    PubMed     Text format    


  246. GUY CD, Diehl AM
    Reply.
    Hepatology. 2016;63:1057-8.
    PubMed     Text format    


  247. ROMAGNOLI R, Mazzaferro V, Bruix J
    Reply.
    Hepatology. 2016;63:1054-5.
    PubMed     Text format    


  248. BOHM M, Vuppalanchi R, Chalasani N
    Febuxostat-induced acute liver injury.
    Hepatology. 2016;63:1047-9.
    PubMed     Text format    


  249. MANN JP, De Vito R, Mosca A, Alisi A, et al
    Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:745-53.
    PubMed     Text format     Abstract available


  250. LEE YH, Kim SU, Song K, Park JY, et al
    Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Hepatology. 2016;63:776-86.
    PubMed     Text format     Abstract available


  251. DIBRA D, Xia X, Mitra A, Cutrera JJ, et al
    Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.
    Hepatology. 2016;63:1000-12.
    PubMed     Text format     Abstract available


  252. DONATI B, Motta BM, Pingitore P, Meroni M, et al
    The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Hepatology. 2016;63:787-98.
    PubMed     Text format     Abstract available


  253. BOURSIER J, Mueller O, Barret M, Machado M, et al
    The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Hepatology. 2016;63:764-75.
    PubMed     Text format     Abstract available


  254. BJORNSSON ES, Olafsson JH
    Concomitant drug-induced liver and skin reactions: An Indian experience.
    Hepatology. 2016;63:700-2.
    PubMed     Text format    


  255. SENIOR JR
    Can rechallenge be done safely after mild or moderate drug-induced liver injury?
    Hepatology. 2016;63:691-3.
    PubMed     Text format    


  256. MEHAL WZ
    We are not in Kansas anymore: The unfamiliar landscape of NASH.
    Hepatology. 2016;63:682-4.
    PubMed     Text format    


  257. RINELLA ME
    Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?--In principle yes, in practice not yet.
    Hepatology. 2016;63:688-90.
    PubMed     Text format    


  258. DEVARBHAVI H, Raj S, Aradya VH, Rangegowda VT, et al
    Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
    Hepatology. 2016;63:993-9.
    PubMed     Text format     Abstract available


  259. WONG VW, Wong GL, Yeung JC, Fung CY, et al
    Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.
    Hepatology. 2016;63:754-63.
    PubMed     Text format     Abstract available


  260. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    February 2016
  261. YAO L, Wang C, Zhang X, Peng L, et al
    Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor-CD36 Pathway to Promote Hepatic Steatosis in Mice.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28518.
    PubMed     Text format     Abstract available


  262. CHEN YY, Jeffery HC, Hunter S, Bhogal R, et al
    Human intrahepatic tregs are functional, require IL-2 from effector cells for survival and are susceptible to fas ligand mediated apoptosis.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28517.
    PubMed     Text format     Abstract available


  263. LEE TH, Rangan V, Khallafi H
    A Case of Sphenoid Sinus Metastasis in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28516.
    PubMed     Text format    


  264. GONG Q, Hu Z, Zhang F, Cui A, et al
    Fibroblast Growth Factor 21 Improves Hepatic Insulin Sensitivity by Inhibiting Mammalian Target of Rapamycin Complex 1.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28523.
    PubMed     Text format     Abstract available


  265. DE WAART DR, Naik J, Utsunomiya KS, Duijst S, et al
    ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28522.
    PubMed     Text format     Abstract available


  266. TANIMIZU N, Kaneko K, Itoh T, Ichinohe N, et al
    Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28521.
    PubMed     Text format     Abstract available


  267. LIU C, Liu L, Chen X, Cheng J, et al
    Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28509.
    PubMed     Text format     Abstract available


  268. LI L, Che L, Tharp KM, Park HM, et al
    Differential Requirement for de novo Lipogenesis in Cholangiocarcinoma and Hepatocellular Carcinoma of Mice and Humans.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28508.
    PubMed     Text format     Abstract available


  269. SIMON TG, Bonilla H, Yan P, Chung RT, et al
    Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and HCC, among patients with HCV Results from ERCHIVES.
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28506.
    PubMed     Text format     Abstract available


  270. D'AMICO G, Malizia G, Bosch J
    Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28502.
    PubMed     Text format    


  271. VILARINHO S, Sari S, Yilmaz G, Stiegler AL, et al
    Recurrent Recessive Mutation in DGUOK Causes Idiopathic Non-Cirrhotic Portal Hypertension.
    Hepatology. 2016 Feb 13. doi: 10.1002/hep.28499.
    PubMed     Text format     Abstract available


  272. CRAIG A, Villanueva A
    Liver Capsule: Molecular-based signatures in hepatocellular carcinoma.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28489.
    PubMed     Text format    


  273. VILAR-GOMEZ E, Yasells-Garcia A, Martinez-Perez Y, Calzadilla-Bertot L, et al
    Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28484.
    PubMed     Text format     Abstract available


  274. TREBICKA J, Schierwagen R
    Hepatic mitochondrial dysfunction in non-alcoholic steatohepatitis: Read-out or reason?
    Hepatology. 2016 Feb 4. doi: 10.1002/hep.28482.
    PubMed     Text format    


  275. TAI WT, Chen YL, Chu PY, Chen LJ, et al
    Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
    Hepatology. 2016 Feb 3. doi: 10.1002/hep.28478.
    PubMed     Text format     Abstract available


  276. SAMI S, Mariella C, Valeria DC, Daniele A, et al
    A low-cost, user-friendly EEG recording system for the assessment of hepatic encephalopathy.
    Hepatology. 2016 Feb 2. doi: 10.1002/hep.28477.
    PubMed     Text format     Abstract available


  277. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:351-3.
    PubMed     Text format    


  278. PANG Q, Qu K, Liu C, Zhang JY, et al
    Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link.
    Hepatology. 2016;63:675.
    PubMed     Text format    


  279. HONG HC, Choi KM
    Reply.
    Hepatology. 2016;63:675-6.
    PubMed     Text format    


  280. SMAGRIS E, BasuRay S, Gromada J, Cohen JC, et al
    Reply.
    Hepatology. 2016;63:677.
    PubMed     Text format    


  281. ZHAO J, Lawless MW
    Resminostat: Opening the door to epigenetic treatments for liver cancer.
    Hepatology. 2016;63:668-9.
    PubMed     Text format    


  282. CUI J, Heba E, Hernandez C, Haufe W, et al
    Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Hepatology. 2016;63:453-61.
    PubMed     Text format     Abstract available


  283. HOLSTER IL, Tjwa ET, Moelker A, Wils A, et al
    Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding.
    Hepatology. 2016;63:581-9.
    PubMed     Text format     Abstract available


  284. BJORNSSON ES, Hoofnagle JH
    Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.
    Hepatology. 2016;63:590-603.
    PubMed     Text format     Abstract available


  285. REID LM, Sethupathy P
    The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
    Hepatology. 2016;63:662-4.
    PubMed     Text format    


    January 2016
  286. TAPPER EB
    Challenge accepted: Confronting readmissions for our patients with cirrhosis.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28471.
    PubMed     Text format    


  287. SACK J, Garcia-Tsao G
    Variceal hemorrhage in a patient with HCV cirrhosis in whom liver synthetic function had normalized after viral elimination.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28470.
    PubMed     Text format    


  288. KOH MY, Gagea M, Sargis T, Lemos R Jr, et al
    A new HIF-1alpha/RANTES driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28468.
    PubMed     Text format     Abstract available


  289. KWO P, Gitlin N, Nahass R, Bernstein D, et al
    Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467.
    PubMed     Text format     Abstract available


  290. NORONHA FERREIRA C, Seijo S, Plessier A, Silva-Junior G, et al
    Natural history and management of esophagogastric varices in chronic non-cirrhotic non-tumoral portal vein thrombosis.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28466.
    PubMed     Text format     Abstract available


  291. CALVISI DF
    Accomplices in Crime: The Diabolical Liaison between PTP1B and Ras in Hepatocellular Carcinoma.
    Hepatology. 2016 Jan 19. doi: 10.1002/hep.28462.
    PubMed     Text format    


  292. LENCIONI R, de Baere T, Soulen MC, Rilling WS, et al
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28453.
    PubMed     Text format     Abstract available


  293. TADDEI T
    Learning from the Melbourne experience: How reliable are cancer registry data for hepatocellular carcinoma?
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28452.
    PubMed     Text format    


  294. DESAI SS, Tung JC, Zhou VX, Grenert JP, et al
    Physiological Ranges of Matrix Rigidity Modulate Primary Mouse Hepatocyte Function In Part Through Hepatocyte Nuclear Factor 4 Alpha.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28450.
    PubMed     Text format     Abstract available


  295. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  296. ZHOU SL, Hu ZQ, Zhou ZJ, Dai Z, et al
    miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28445.
    PubMed     Text format     Abstract available


  297. ZHAO L, Wong LL, Shi X, Ji J, et al
    Should hepatic dysplasia nodules and regenerative nodules be regarded as pre-malignant lesions and treated?
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28444.
    PubMed     Text format    


  298. SUNAMI Y, Ringelhan M, Kokai E, Lu M, et al
    Canonical NF-kappaB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28435.
    PubMed     Text format     Abstract available



  299. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis.
    Hepatology. 2016;63:349.
    PubMed     Text format    



  300. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
    Hepatology. 2016;63:349.
    PubMed     Text format    


  301. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1-3.
    PubMed     Text format    


  302. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  303. DONG C, Peng S
    Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China.
    Hepatology. 2016;63:347-8.
    PubMed     Text format    


  304. ZHANG Z, Gao B, Wang FS
    Reply.
    Hepatology. 2016;63:348.
    PubMed     Text format    


  305. GIANNINI EG, Stravitz RT, Caldwell SH
    Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see.
    Hepatology. 2016;63:342-3.
    PubMed     Text format    


  306. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


  307. ROSSO C, Mezzabotta L, Gaggini M, Salomone F, et al
    Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.
    Hepatology. 2016;63:107-16.
    PubMed     Text format     Abstract available


  308. GOFFREDO M, Caprio S, Feldstein AE, D'Adamo E, et al
    Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
    Hepatology. 2016;63:117-25.
    PubMed     Text format     Abstract available


  309. DUFOUR JF
    Time to Abandon NASH?
    Hepatology. 2016;63:9-10.
    PubMed     Text format    


  310. KOEHLER EM, Plompen EP, Schouten JN, Hansen BE, et al
    Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
    Hepatology. 2016;63:138-47.
    PubMed     Text format     Abstract available


    December 2015
  311. WANG PX, Zhang XJ, Li H
    IRFs in hepatocytes pathophysiology.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28433.
    PubMed     Text format    


  312. OH Y, Park O, Swierczewska M, Hamilton JP, et al
    Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28432.
    PubMed     Text format     Abstract available


  313. INTAGLIATA NM, Caldwell SH, Porte RJ, Lisman T, et al
    Prediction of bleeding in cirrhosis patients: Is the forecast any clearer?
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28426.
    PubMed     Text format    


  314. LAWITZ E, Matusow G, DeJesus E, Yoshida EM, et al
    Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A Phase 3 study (OPTIMIST-2).
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28422.
    PubMed     Text format     Abstract available


  315. TANOUE S, Kaplan DE
    CD14 regulatory Dendritic Cells in Hepatocellular Carcinoma and Cirrhotic patients.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28419.
    PubMed     Text format    


  316. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


  317. XIAO S, Chang RM, Yang MY, Lei X, et al
    ACTL6A predicts poor prognosis of Hepatocellular carcinoma and promotes metastasis and Epithelial-mesenchymal transition.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28417.
    PubMed     Text format     Abstract available


  318. WANG MD, Wu H, Fu GB, Zhang HL, et al
    Acetyl-CoA carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28415.
    PubMed     Text format     Abstract available


  319. BAJAJ JS, Reddy KR, Tandon P, Wong F, et al
    The Three-Month Readmission Rate Remains Unacceptably High in a Large North American Cohort of Cirrhotic Patients.
    Hepatology. 2015 Dec 21. doi: 10.1002/hep.28414.
    PubMed     Text format     Abstract available


  320. IWAGAMI Y, Huang CK, Olsen MJ, Thomas JM, et al
    Aspartate beta-hydroxylase modulates cellular senescence via glycogen synthase kinase 3beta in hepatocellular carcinoma.
    Hepatology. 2015 Dec 19. doi: 10.1002/hep.28411.
    PubMed     Text format     Abstract available


  321. FURUTA K, Yoshida Y, Ogura S, Kurahashi T, et al
    Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen-induced liver injury in mice.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28410.
    PubMed     Text format     Abstract available


  322. GUO Y, Wang J, Zhang L, Shen S, et al
    Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28409.
    PubMed     Text format     Abstract available


  323. MEHTA N, Yao FY
    Nucleos(t)ide analogues to reduce the risk of Hepatitis B associated hepatocellular carcinoma: A can't miss proposition?
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28404.
    PubMed     Text format    


  324. ZHOU CC, Yang F, Yuan SX, Ma JZ, et al
    Systemic genome screening identified the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28393.
    PubMed     Text format     Abstract available


  325. OUYANG HY, Xu J, Luo J, Zou RH, et al
    MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28397.
    PubMed     Text format     Abstract available


  326. CAVALLIN M, Piano S, Romano A, Fasolato S, et al
    Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28396.
    PubMed     Text format     Abstract available


  327. ZHANG Y, Liu Y, Duan J, Yan H, et al
    Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21 stabilization via activating ERK1/2-MAPK pathway.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28395.
    PubMed     Text format     Abstract available


  328. LAN X, Yan J, Ren J, Zhong B, et al
    A Novel Long Non-coding RNA Lnc-HC Binds hnRNPA2B1 to Regulate Expressions of Cyp7a1 and Abca1 in Hepatocytic Cholesterol Metabolism.
    Hepatology. 2015 Dec 11. doi: 10.1002/hep.28391.
    PubMed     Text format     Abstract available


  329. TOSELLO-TRAMPONT AC, Krueger P, Narayanan S, Landes SG, et al
    NKp46 NK cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28389.
    PubMed     Text format     Abstract available


  330. CHEN DS, Liaw YF, Chen CJ, Wu JC, et al
    Differences in hepatitis viral etiology of hepatocellular carcinoma in Taiwan and China.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28378.
    PubMed     Text format    


  331. LOCATELLI L, Cadamuro M, Spirli C, Fiorotto R, et al
    Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.
    Hepatology. 2015 Dec 8. doi: 10.1002/hep.28382.
    PubMed     Text format     Abstract available


  332. SEKI E
    HEDGEHOG signal in Hepatocytes mediates Macrophage Recruitment: A New Mechanism and Potential Therapeutic Target for Fatty Liver Disease.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28381.
    PubMed     Text format    


  333. CHO NE, Bang BR, Gurung P, Li M, et al
    Retinoid Regulation of Antiviral Innate Immunity in Hepatocytes.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28380.
    PubMed     Text format     Abstract available


  334. EKSTEEN B
    Predicting risk in Primary Biliary Cholangitis.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28377.
    PubMed     Text format    



  335. 2015 Hepatology referees (volumes 61 and 62).
    Hepatology. 2015;62:1926-1930.
    PubMed     Text format    


  336. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:1649-1651.
    PubMed     Text format    


    November 2015
  337. GUO H, Jing L, Cheng Y, Atsaves V, et al
    Downregulation of the Cyclin-Dependent Kinase Inhibitor p57 Is Mediated by Jab1/Csn5 in Hepatocarcinogenesis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28372.
    PubMed     Text format     Abstract available


  338. BLASI A, Hernandez-Gea V, Reverter JC, Garcia-Pagan JC, et al
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28371.
    PubMed     Text format    


  339. QI X, De Stefano V, Guo X
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28369.
    PubMed     Text format    


  340. BOSSEN L, Krag A, Vilstrup H, Watson H, et al
    Non-selective beta-blockers do not affect mortality in cirrhosis patients with ascites: Post hoc analysis of three RCTs with 1198 patients.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28352.
    PubMed     Text format     Abstract available


  341. PISCAGLIA F, Svegliati-Baroni G, Barchetti A, Pecorelli A, et al
    Clinical patterns of hepatocellular carcinoma (hcc) in non alcoholic fatty liver disease (NAFLD): A multicenter prospective study.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28368.
    PubMed     Text format     Abstract available


  342. JUNG KH, Zhang J, Zhou C, Shen H, et al
    Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28367.
    PubMed     Text format     Abstract available


  343. REYES H
    Sulfated progesterone metabolites in the pathogenesis of intrahepatic cholestasis of pregnancy: Another loop in the ascending spiral of medical knowledge.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28365.
    PubMed     Text format    


  344. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  345. GALUN E
    Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor-promoting niche (TPN) in the development of hepatocellular carcinoma.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28344.
    PubMed     Text format    


  346. DOSHI M, Pereira K, Carrion A, Martin P, et al
    Antegrade embolization of spontaneous splenorenal shunt for Post-TIPS refractory Hepatic Encephalopathy.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28343.
    PubMed     Text format    


  347. YAO FY, Fidelman N
    Re-accessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand with Tumor Down-staging?
    Hepatology. 2015 Nov 11. doi: 10.1002/hep.28139.
    PubMed     Text format     Abstract available


  348. DESBOROUGH MJ, Jairath V
    Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy.
    Hepatology. 2015 Nov 6. doi: 10.1002/hep.28336.
    PubMed     Text format    


  349. SOWA JP, Fingas CD, Canbay A
    Mixed lineage kinase 3 connects hepatocellular lipotoxicity with macrophage chemotaxis.
    Hepatology. 2015 Nov 6. doi: 10.1002/hep.28333.
    PubMed     Text format    


  350. MERLI M, Lucidi C, Di Gregorio V, Lattanzi B, et al
    An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics: A randomized trial.
    Hepatology. 2015 Nov 3. doi: 10.1002/hep.28332.
    PubMed     Text format     Abstract available


  351. FERNANDEZ J, Tandon P, Mensa J, Garcia-Tsao G, et al
    Antibiotic prophylaxis in cirrhosis: Good and bad.
    Hepatology. 2015 Nov 3. doi: 10.1002/hep.28330.
    PubMed     Text format     Abstract available


  352. LANZONI G, Cardinale V, Carpino G
    The hepatic, biliary and pancreatic network of stem/progenitor cells niches in humans: A new reference frame for disease and regeneration.
    Hepatology. 2015 Nov 2. doi: 10.1002/hep.28326.
    PubMed     Text format     Abstract available


  353. VASUDEVAN A, Ardalan Z, Gow P, Angus P, et al
    Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndrome.
    Hepatology. 2015 Nov 2. doi: 10.1002/hep.28325.
    PubMed     Text format    


  354. CAVALLIN M, Piano S, Angeli P
    Outpatients use of terlipressin for hepatorenal syndrome: Not for all, with caution and a wise liver transplant allocation policy.
    Hepatology. 2015 Nov 2. doi: 10.1002/hep.28324.
    PubMed     Text format    


  355. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:1331-3.
    PubMed     Text format    


  356. JAESCHKE H, Du K
    Benzyl Alcohol: A novel treatment for acetaminophen overdose?
    Hepatology. 2015;62:1641-2.
    PubMed     Text format    


  357. ZUCKERBRAUN BS, Cai C, Billiar TR
    Reply: To PMID 24798499.
    Hepatology. 2015;62:1642.
    PubMed     Text format    


  358. YANG T, Zhang H, Lau WY, Shen F, et al
    Liver disease in China: A long way to go.
    Hepatology. 2015;62:1640.
    PubMed     Text format    


  359. ZHANG Z, Fan JG, Wang FS
    Reply: To PMID 25164003.
    Hepatology. 2015;62:1640-1.
    PubMed     Text format    


  360. BLECHACZ B, Mishra L
    Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice.
    Hepatology. 2015;62:1645.
    PubMed     Text format    


  361. LEUNG DH, Khan M, Minard CG, Guffey D, et al
    Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Hepatology. 2015;62:1576-83.
    PubMed     Text format     Abstract available


  362. SIDDIQUE HR, Feldman DE, Chen CL, Punj V, et al
    NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Hepatology. 2015;62:1466-79.
    PubMed     Text format     Abstract available


  363. JO YS, Ryu D, Maida A, Wang X, et al
    Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.
    Hepatology. 2015;62:1606-18.
    PubMed     Text format     Abstract available


  364. HAGIWARA S, Nishida N, Park AM, Sakurai T, et al
    Impaired expression of ATP-binding cassette transporter G2 and liver damage in erythropoietic protoporphyria.
    Hepatology. 2015;62:1638-9.
    PubMed     Text format    


    October 2015
  365. LEE MS
    Clinical characteristics and outcomes of pyogenic vertebral osteomyelitis in patients with cirrhosis.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28319.
    PubMed     Text format    


  366. LAI JC, Dodge JL, Sen S, Covinsky K, et al
    Functional Decline in Patients with Cirrhosis Awaiting Liver Transplantation: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28316.
    PubMed     Text format     Abstract available


  367. ALISON MR, Lin WR
    Hepatocytes come out of left field.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28315.
    PubMed     Text format    


  368. AGUERO F, Forner A, Manzardo C, Valdivieso A, et al
    HIV Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28321.
    PubMed     Text format     Abstract available


  369. YOKOMORI H, Yamazaki H, Oda M
    Freshwater clam extract supplement induced acute cholestasis.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28320.
    PubMed     Text format    


  370. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  371. URBAN S
    Entry and entry inhibition of Hepatitis B (HBV) and Hepatitis Delta Virus (HDV) into hepatocytes.
    Hepatology. 2015 Oct 26. doi: 10.1002/hep.28308.
    PubMed     Text format    


  372. WONG CM, Lai W, Law CT, Ho DW, et al
    Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Hepatology. 2015 Oct 20. doi: 10.1002/hep.28304.
    PubMed     Text format     Abstract available


  373. RUIVARD M, Laine F, Deugnier Y
    Iron absorption in Nonalcoholic Steatohepatitis (NASH) and Dysmetabolic iron overload syndrome (DIOS).
    Hepatology. 2015 Oct 17. doi: 10.1002/hep.28296.
    PubMed     Text format    


  374. DELAUNAY JL, Durand-Schneider AM, Dossier C, Falguieres T, et al
    A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3.
    Hepatology. 2015 Oct 17. doi: 10.1002/hep.28300.
    PubMed     Text format     Abstract available


  375. ALBILLOS A, Martinez J, Tellez L
    Continued controversy over the safety of beta-blockers in decompensated cirrhosis.
    Hepatology. 2015 Oct 16. doi: 10.1002/hep.28293.
    PubMed     Text format    


  376. RAHIMI RS, O'Leary JG
    Transfusing Common Sense Instead of Blood Products into Coagulation Testing in Patients with Cirrhosis: Overtreatment not equal Safety.
    Hepatology. 2015 Oct 16. doi: 10.1002/hep.28291.
    PubMed     Text format    


  377. KWON H, Song K, Han C, Chen W, et al
    Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease (NAFLD).
    Hepatology. 2015 Oct 16. doi: 10.1002/hep.28289.
    PubMed     Text format     Abstract available


  378. ZIMMERMANN HW, Bruns T, Weston CJ, Curbishley SM, et al
    Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver.
    Hepatology. 2015 Oct 16. doi: 10.1002/hep.28285.
    PubMed     Text format     Abstract available


  379. REYES H
    What have we learned about Intrahepatic Cholestasis of Pregnancy?
    Hepatology. 2015 Oct 16. doi: 10.1002/hep.28295.
    PubMed     Text format    


  380. KIM SH, Jeon Y, Kim HS, Lee JK, et al
    Hepatocyte homeostasis for chromosome ploidization and liver function is regulated by Ssu72 protein phosphatase.
    Hepatology. 2015 Oct 12. doi: 10.1002/hep.28281.
    PubMed     Text format     Abstract available


  381. PUBLICOVER J, Jespersen JM, Johnson AJ, Nishimura SL, et al
    Age-influenced hepatic immune priming determines HBV infection fate; implications from Mouse to Man.
    Hepatology. 2015 Oct 12. doi: 10.1002/hep.28284.
    PubMed     Text format    


  382. AHMED A, Perumpail RB, Harrison SA
    High Prevalence of Hepatic Fibrosis in the Setting of Coexisting Diabetes and Hepatic Steatosis: A Case for Selective Screening in General Population?
    Hepatology. 2015 Oct 9. doi: 10.1002/hep.28277.
    PubMed     Text format    


  383. PENG ZW, Ikenaga N, Liu SB, Sverdlov DY, et al
    Integrin alphavbeta6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis and tumorigenesis.
    Hepatology. 2015 Oct 8. doi: 10.1002/hep.28274.
    PubMed     Text format     Abstract available


  384. RIPOLL C
    Non-invasive predictors of fibrosis in NASH with and without cirrhosis, just as good as histology (and HVPG?).
    Hepatology. 2015 Oct 8. doi: 10.1002/hep.28273.
    PubMed     Text format    


  385. LI Z, Feng J, Sun X
    Hypomethylation and hypohydroxymethylation of DNA in hepatocellular carcinoma and cholangiocarcinoma.
    Hepatology. 2015 Oct 5. doi: 10.1002/hep.28272.
    PubMed     Text format    


  386. HONG T, Gow P, Fink M, Dev A, et al
    Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
    Hepatology. 2015 Oct 5. doi: 10.1002/hep.28267.
    PubMed     Text format     Abstract available


  387. LEE TY, Lin JT, Zeng YS, Chen YJ, et al
    Association between nucleos(t)ide analogue and tumor recurrence in HBV-related hepatocellular carcinoma after radiofrequency ablation.
    Hepatology. 2015 Oct 1. doi: 10.1002/hep.28266.
    PubMed     Text format     Abstract available


  388. ABU-HAYYEH S, Ovadia C, Lieu T, Jensen DD, et al
    Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum.
    Hepatology. 2015 Oct 1. doi: 10.1002/hep.28265.
    PubMed     Text format     Abstract available


  389. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:985-7.
    PubMed     Text format    


  390. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  391. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


  392. CLOSS EI
    Putative role of cationic amino acid transporter-3 in murine liver metabolism.
    Hepatology. 2015;62:1326-7.
    PubMed     Text format    


  393. GU Q, Cui Z
    Reply: To PMID 25130427.
    Hepatology. 2015;62:1327.
    PubMed     Text format    


  394. DALY AK, Day CP, Liu YL, Anstee QM, et al
    TM6SF2 as a genetic risk factor for fibrosis.
    Hepatology. 2015;62:1321.
    PubMed     Text format    


  395. SOOKOIAN S, Pirola CJ
    Reply: To PMID 25302781.
    Hepatology. 2015;62:1321-2.
    PubMed     Text format    


  396. VERMA M, Navarro V
    Patient-centered care: a new paradigm for chronic liver disease.
    Hepatology. 2015;62:988-90.
    PubMed     Text format    


  397. LEE YK, Jee BA, Kwon SM, Yoon YS, et al
    Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression.
    Hepatology. 2015;62:1174-89.
    PubMed     Text format     Abstract available


  398. TOROK NJ
    Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?
    Hepatology. 2015;62:1313-5.
    PubMed     Text format    


  399. GUO W, Qiu Z, Wang Z, Wang Q, et al
    MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
    Hepatology. 2015;62:1132-44.
    PubMed     Text format     Abstract available


  400. CHANG B, Xu MJ, Zhou Z, Cai Y, et al
    Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.
    Hepatology. 2015;62:1070-85.
    PubMed     Text format     Abstract available


  401. PETTA S, Maida M, Macaluso FS, Di Marco V, et al
    The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.
    Hepatology. 2015;62:1101-10.
    PubMed     Text format     Abstract available


  402. LAI M
    Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?
    Hepatology. 2015;62:997-8.
    PubMed     Text format    


    September 2015
  403. VILLANUEVA C, Albillos A, Genesca J, Abraldes JG, et al
    Development of hyperdynamic circulation and response to beta-blockers in compensated cirrhosis with portal hypertension.
    Hepatology. 2015 Sep 30. doi: 10.1002/hep.28264.
    PubMed     Text format     Abstract available


  404. BESSON-FOURNIER C, Martinez M, Vinel JP, Aguilar-Martinez P, et al
    Further support for the association of GNPAT variant rs11558492 with severe iron overload in hemochromatosis.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28259.
    PubMed     Text format    


  405. YANG X, Chao X, Wang ZT, Ding WX, et al
    The End of RIPK1-RIPK3-MLKL-Mediated Necroptosis in Acetaminophen-Induced Hepatotoxicity?
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28263.
    PubMed     Text format    


  406. ZHOU M, Marc Learned R, Rossi SJ, DePaoli AM, et al
    Engineered FGF19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28257.
    PubMed     Text format     Abstract available


  407. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


  408. LATOUR C, Besson-Fournier C, Meynard D, Silvestri L, et al
    Differing impact of the deletion of hemochromatosis-associated molecules HFE and TFR2 on the iron phenotype of mice lacking BMP6 or HJV.
    Hepatology. 2015 Sep 25. doi: 10.1002/hep.28254.
    PubMed     Text format     Abstract available


  409. IBRAHIM SH, Hirsova P, Tomita K, Bronk SF, et al
    Mixed Lineage Kinase 3 Mediates Release of C-X-C Motif Ligand 10-Bearing Chemotactic Extracellular Vesicles from Lipotoxic Hepatocytes.
    Hepatology. 2015 Sep 25. doi: 10.1002/hep.28252.
    PubMed     Text format     Abstract available


  410. SUN X, Ou Z, Chen R, Niu X, et al
    Activation of the p62-Keap1-NRF2 Pathway Protects against Ferroptosis in Hepatocellular Carcinoma Cells.
    Hepatology. 2015 Sep 24. doi: 10.1002/hep.28251.
    PubMed     Text format     Abstract available


  411. FERNANDEZ-VARO G, Oro D, Cable EE, Reichenbach V, et al
    Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.
    Hepatology. 2015 Sep 24. doi: 10.1002/hep.28250.
    PubMed     Text format     Abstract available


  412. HAGIWARA S, Nishida N, Kudo M
    Hepatocyte damage due to protoporphyrin deposition.
    Hepatology. 2015 Sep 24. doi: 10.1002/hep.28248.
    PubMed     Text format    


  413. SHOUKRY NH, Fabre T, Gandhi CR
    A novel role for hepatic stellate cells in pathogenesis of visceral leishmaniasis.
    Hepatology. 2015 Sep 24. doi: 10.1002/hep.28247.
    PubMed     Text format    


  414. BERASAIN C, Avila MA
    Further evidence on the Janus-faced nature of the Epidermal Growth Factor Receptor: from liver regeneration to hepatocarcinogenesis.
    Hepatology. 2015 Sep 24. doi: 10.1002/hep.28246.
    PubMed     Text format    


  415. YOSHIMURA K, Okanoue T, Ebise H, Iwasaki T, et al
    Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining.
    Hepatology. 2015 Sep 21. doi: 10.1002/hep.28226.
    PubMed     Text format     Abstract available


  416. SCHNEIDER AT, Gautheron J, Tacke F, Vucur M, et al
    Receptor Interacting Protein Kinase-1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity.
    Hepatology. 2015 Sep 21. doi: 10.1002/hep.28225.
    PubMed     Text format    


  417. PARK YY, Sohn BH, Johnson RL, Kang MH, et al
    YAP1 and TAZ Activates mTORC1 Pathway by Regulating Amino Acid Transporters in hepatocellular carcinoma.
    Hepatology. 2015 Sep 21. doi: 10.1002/hep.28223.
    PubMed     Text format     Abstract available


  418. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
    Hepatology. 2015 Sep 15. doi: 10.1002/hep.28140.
    PubMed     Text format    


  419. YANG LX, Gao Q, Shi JY, Wang ZC, et al
    The MAPK Kinase Kinase 4 Deficiency in Intrahepatic Cholangiocarcinoma Leads to Invasive Growth and Epithelial-Mesenchymal Transition.
    Hepatology. 2015 Sep 4. doi: 10.1002/hep.28149.
    PubMed     Text format     Abstract available


  420. DE PIETRI L, Bianchini M, Montalti R, De Maria N, et al
    Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy. A randomized controlled trial.
    Hepatology. 2015 Sep 4. doi: 10.1002/hep.28148.
    PubMed     Text format     Abstract available


  421. MATO JM, Lu SC
    LRH-1 and transmethylation fluxes in non-alcoholic steatohepatitis.
    Hepatology. 2015 Sep 3. doi: 10.1002/hep.28146.
    PubMed     Text format    


  422. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:663-5.
    PubMed     Text format    


  423. HSU SH, Duncan AW
    Pathological polyploidy in liver disease.
    Hepatology. 2015;62:968-70.
    PubMed     Text format    


  424. WANG C, Hu KQ, Yang Y
    Reply: To PMID 25284802.
    Hepatology. 2015;62:980-1.
    PubMed     Text format    


  425. BERZIGOTTI A, Reig M, Bruix J
    Reply: To PMID 25212123.
    Hepatology. 2015;62:978-9.
    PubMed     Text format    


  426. ALKOZAI EM, van Faassen M, Kema IP, Porte RJ, et al
    Evidence against a role of serotonin in liver regeneration in humans.
    Hepatology. 2015;62:983.
    PubMed     Text format    


  427. STARLINGER P, Brostjan C, Gruenberger T
    Reply: To PMID 24277679.
    Hepatology. 2015;62:984.
    PubMed     Text format    


  428. KIM SH, Saide K, Farrell J, Faulkner L, et al
    Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
    Hepatology. 2015;62:887-99.
    PubMed     Text format     Abstract available


  429. ZHOU JN, Zeng Q, Wang HY, Zhang B, et al
    MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Hepatology. 2015;62:801-15.
    PubMed     Text format     Abstract available


  430. REIG M, Bruix J
    Pattern of tumor progression in liver cancer: The missing partner in trial design.
    Hepatology. 2015;62:674-6.
    PubMed     Text format    


  431. VANWAGNER LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, et al
    Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
    Hepatology. 2015;62:773-83.
    PubMed     Text format     Abstract available


  432. BUTLER NS, Schmidt NW
    Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis.
    Hepatology. 2015;62:680-3.
    PubMed     Text format    


  433. NAULT JC, Rebouissou S, Zucman Rossi J
    NRF2/KEAP1 and Wnt/beta-catenin in the multistep process of liver carcinogenesis in humans and rats.
    Hepatology. 2015;62:677-9.
    PubMed     Text format    


  434. HOKI T, Miyanishi K, Tanaka S, Takada K, et al
    Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis.
    Hepatology. 2015;62:751-61.
    PubMed     Text format     Abstract available


  435. MARZANO C, Cazals-Hatem D, Rautou PE, Valla DC, et al
    The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome.
    Hepatology. 2015;62:956-63.
    PubMed     Text format     Abstract available


    August 2015
  436. ONALI S, Figorilli F, O'Beirne J, Sauchuk M, et al
    Selection criteria for resection in hepatocellular carcinoma: Can we expand them?
    Hepatology. 2015 Aug 28. doi: 10.1002/hep.28141.
    PubMed     Text format    


  437. LOPEZ-LUQUE J, Caballero-Diaz D, Martinez-Palacian A, Roncero C, et al
    Dissecting the role of the Epidermal Growth Factor Receptor catalytic activity during liver regeneration and hepatocarcinogenesis.
    Hepatology. 2015 Aug 27. doi: 10.1002/hep.28134.
    PubMed     Text format     Abstract available


  438. GORHAM JD, Gleeson MW
    Cirrhosis and dysbiosis: New insights from next generation sequencing.
    Hepatology. 2015 Aug 27. doi: 10.1002/hep.28133.
    PubMed     Text format    


  439. KHADEM F, Gao X, Mou Z, Jia P, et al
    Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through p110delta-dependent induction and expansion of Tregs in mice.
    Hepatology. 2015 Aug 20. doi: 10.1002/hep.28130.
    PubMed     Text format     Abstract available


  440. TRIVEDI PJ, Corpechot C, Pares A, Hirschfield GM, et al
    Risk Stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists.
    Hepatology. 2015 Aug 20. doi: 10.1002/hep.28128.
    PubMed     Text format     Abstract available


  441. HAAS JT, Staels B
    CETP: A Kupffer cell marker linking hepatic inflammation with atherogenic dyslipidemia?
    Hepatology. 2015 Aug 17. doi: 10.1002/hep.28125.
    PubMed     Text format    


  442. YOUNOSSI ZM, Otgonsuren M, Henry L, Venkatesan C, et al
    Association of Non-alcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States from 2004-2009.
    Hepatology. 2015 Aug 14. doi: 10.1002/hep.28123.
    PubMed     Text format     Abstract available


  443. SHIMODA S, Hisamoto S, Harada K, Iwasaka S, et al
    Natural killer cells regulate T cell immune responses in primary biliary cirrhosis.
    Hepatology. 2015 Aug 11. doi: 10.1002/hep.28122.
    PubMed     Text format     Abstract available


  444. KAO D, Roach B, Park H, Hotte N, et al
    Fecal microbiota transplantation (FMT) in the management of hepatic encephalopathy (HE).
    Hepatology. 2015 Aug 11. doi: 10.1002/hep.28121.
    PubMed     Text format    


  445. WONG DK
    Hepatoma in hepatitis B - Infectious disease or Liver disease?
    Hepatology. 2015 Aug 7. doi: 10.1002/hep.28118.
    PubMed     Text format    


  446. GUAN DX, Shi J, Zhang Y, Zhao JS, et al
    Sorafenib enriches EpCAM positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.
    Hepatology. 2015 Aug 7. doi: 10.1002/hep.28117.
    PubMed     Text format     Abstract available


  447. JUNG KS, Kim SU, Song K, Park JY, et al
    Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28115.
    PubMed     Text format     Abstract available


  448. FUJII Y, Uchida Y, Mochida S
    Reply to the Letter Entitled "Severe Hepatotoxicity Associated with Asunaprevir and Daclatasvir in Chronic Hepatitis C".
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28114.
    PubMed     Text format    


  449. SHIBATA S, Umemura T, Komatsu M, Tanaka E, et al
    Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28113.
    PubMed     Text format    


  450. FUJITA T, Soontrapa K, Ito Y, Iwaisako K, et al
    Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28112.
    PubMed     Text format     Abstract available


  451. SANCHEZ W, Kamath PS
    The shear effort of measurement of portal hypertension.
    Hepatology. 2015 Aug 3. doi: 10.1002/hep.28027.
    PubMed     Text format    


  452. SILVA-JUNIOR G, Baiges A, Turon F, Torres F, et al
    The prognostic value of HVPG in patients with cirrhosis is highly dependent on the accuracy of the technique.
    Hepatology. 2015 Aug 3. doi: 10.1002/hep.28031.
    PubMed     Text format     Abstract available


  453. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:327-9.
    PubMed     Text format    


  454. PAUR J, Nika L, Maier C, Moscu-Gregor A, et al
    Fibroblast growth factor receptor 3 isoforms: novel therapeutic targets for hepatocellular carcinoma?
    Hepatology. 2015 Aug 1. doi: 10.1002/hep.28023.
    PubMed     Text format     Abstract available


  455. LIU RX, Wei Y, Zeng QH, Chan KW, et al
    CXCR3 B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.
    Hepatology. 2015 Aug 1. doi: 10.1002/hep.28020.
    PubMed     Text format     Abstract available


  456. TUOMINEN I, Beaven SW
    Intestinal farnesoid X receptor puts a fresh coat of wax on fatty liver.
    Hepatology. 2015;62:646-8.
    PubMed     Text format    


  457. LO GH
    Lack of difference among vasoconstrictors: Similar effectiveness or similar ineffectiveness?
    Hepatology. 2015;62:653.
    PubMed     Text format    


  458. SEO YS, Jung CH, Kim TH, Yim SY, et al
    Reply: To PMID 24415445.
    Hepatology. 2015;62:653-4.
    PubMed     Text format    


  459. MUSSO G, Cassader M, Gambino R
    PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease.
    Hepatology. 2015;62:658-9.
    PubMed     Text format    


  460. ROMEO S, Dongiovanni P, Petta S, Pihalajamaki J, et al
    Reply: To PMID 25251399.
    Hepatology. 2015;62:660.
    PubMed     Text format    


  461. QI X, Guo X, Fan D
    Difference in Budd-Chiari syndrome between the West and China.
    Hepatology. 2015;62:656.
    PubMed     Text format    


  462. FAN JG, Wang FS
    Reply: To PMID 19399912.
    Hepatology. 2015;62:657.
    PubMed     Text format    


  463. CUNNINGHAM SC, Siew SM, Hallwirth CV, Bolitho C, et al
    Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.
    Hepatology. 2015;62:417-28.
    PubMed     Text format     Abstract available


  464. HANLEY KL, Feng GS
    A new VETC in hepatocellular carcinoma metastasis.
    Hepatology. 2015;62:343-5.
    PubMed     Text format    


  465. ANTOINE DJ, Sabbisetti VS, Francis B, Jorgensen AL, et al
    Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury.
    Hepatology. 2015;62:591-9.
    PubMed     Text format     Abstract available


  466. THOMPSON RJ, Bull LN
    Treating genetic disease: Expanding the options.
    Hepatology. 2015;62:349-51.
    PubMed     Text format    


  467. CHUANG KH, Whitney-Miller CL, Chu CY, Zhou Z, et al
    MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
    Hepatology. 2015;62:466-80.
    PubMed     Text format     Abstract available


  468. TOROK NJ, Dranoff JA, Schuppan D, Friedman SL, et al
    Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.
    Hepatology. 2015;62:627-34.
    PubMed     Text format     Abstract available


  469. MCLAREN CE, Emond MJ, Subramaniam VN, Phatak PD, et al
    Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.
    Hepatology. 2015;62:429-39.
    PubMed     Text format     Abstract available


    July 2015
  470. BANNAS P, Kramer H, Hernando D, Agni R, et al
    Quantitative MR Imaging of Hepatic Steatosis: Validation in Ex Vivo Human Livers.
    Hepatology. 2015 Jul 29. doi: 10.1002/hep.28012.
    PubMed     Text format     Abstract available


  471. CARBONE M, Sharp SJ, Flack S, Paximadas D, et al
    The UK-PBC Risk Scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis.
    Hepatology. 2015 Jul 29. doi: 10.1002/hep.28017.
    PubMed     Text format     Abstract available


  472. ARGO CK, Ikura Y, Lackner C, Caldwell SH, et al
    The fat droplet in hepatocellular ballooning and implications for scoring NASH therapeutic response.
    Hepatology. 2015 Jul 23. doi: 10.1002/hep.28009.
    PubMed     Text format    


  473. LO GH
    Is cryoablation really more effective than radiofrequency ablation in hepatocellular carcinoma?
    Hepatology. 2015 Jul 23. doi: 10.1002/hep.28005.
    PubMed     Text format    


  474. KAMADA Y, Ono M, Hyogo H, Fujii H, et al
    A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers.
    Hepatology. 2015 Jul 21. doi: 10.1002/hep.28002.
    PubMed     Text format     Abstract available


  475. SINGH S, Khera R, Allen AM, Murad MH, et al
    Comparative effectiveness of pharmacological interventions for non-alcoholic steatohepatitis: A systematic review and network meta-analysis.
    Hepatology. 2015 Jul 18. doi: 10.1002/hep.27999.
    PubMed     Text format     Abstract available


  476. CHUA HH, Tsuei DJ, Lee PH, Jeng YM, et al
    RBMY, a novel inhibitor of GSK3beta, increases tumor stemness and predicts poor prognosis of hepatocellular Carcinoma.
    Hepatology. 2015 Jul 16. doi: 10.1002/hep.27996.
    PubMed     Text format     Abstract available


  477. BAJAJ JS
    Liver Capsule: Hepatic Encephalopathy.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27984.
    PubMed     Text format    


  478. SCHNEIDER KM, Bieghs V, Heymann F, Hu W, et al
    CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27982.
    PubMed     Text format     Abstract available


  479. YANG T, Lau WY, Zhang H, Wu MC, et al
    Hepatic surgeons are like the child who rescued dying fishes.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27980.
    PubMed     Text format    


  480. HENRY ZH, Northup PG
    Baclofen for the treatment of muscle cramps in patients with cirrhosis: A new alternative.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27988.
    PubMed     Text format     Abstract available


  481. SHIMAZU Y, Hamaguchi M, Fukuda T, Yamaguchi K, et al
    Steatohepatitis as impaired immune metabolism induced by liver resident regulatory T-cell depletion.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27986.
    PubMed     Text format     Abstract available


  482. WON C, Kim BH, Hee Yi E, Choi KJ, et al
    STAT3-mediated CD133 upregulation contributes to promotion of hepatocellular carcinoma.
    Hepatology. 2015 Jul 6. doi: 10.1002/hep.27968.
    PubMed     Text format     Abstract available


  483. KUMADA H, Chayama K, Rodrigues-Jr L, Suzuki F, et al
    Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir for HCV Genotype 1b-infected Japanese Patients With or Without Cirrhosis.
    Hepatology. 2015 Jul 3. doi: 10.1002/hep.27972.
    PubMed     Text format     Abstract available


  484. DE MARTEL C, Maucort-Boulch D, Plummer M, Franceschi S, et al
    Worldwide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
    Hepatology. 2015 Jul 3. doi: 10.1002/hep.27969.
    PubMed     Text format     Abstract available


  485. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:1-3.
    PubMed     Text format    


  486. KAYADIBI H, Sertoglu E, Uyanik M
    Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2015;62:324-5.
    PubMed     Text format    


  487. LI XY, Bai MJ, Chen LJ, Xu JL, et al
    Issue in statistical strategy in case-control study.
    Hepatology. 2015;62:320.
    PubMed     Text format    


  488. ALEKSANDROVA K, Pischon T
    Reply.
    Hepatology. 2015;62:320-1.
    PubMed     Text format    


  489. STARLINGER P, Lesurtel M, Brostjan C, Clavien PA, et al
    Reply.
    Hepatology. 2015;62:319-20.
    PubMed     Text format    


  490. PANG Q, Liu C, Zhang JY, Qu K, et al
    Serotonin in liver tumor: Friend or foe?
    Hepatology. 2015;62:319.
    PubMed     Text format    


  491. GUSTOT T, Fernandez J, Garcia E, Morando F, et al
    Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.
    Hepatology. 2015;62:243-52.
    PubMed     Text format     Abstract available


  492. TAFALENG EN, Chakraborty S, Han B, Hale P, et al
    Induced pluripotent stem cells model personalized variations in liver disease resulting from alpha1-antitrypsin deficiency.
    Hepatology. 2015;62:147-57.
    PubMed     Text format     Abstract available


  493. SAMPAZIOTIS F, Segeritz CP, Vallier L
    Potential of human induced pluripotent stem cells in studies of liver disease.
    Hepatology. 2015;62:303-11.
    PubMed     Text format     Abstract available


    June 2015
  494. MANENTI A, Pavesi E, Farinetti A, Colasanto D, et al
    A morpho-dynamic evaluation of the portal and hepatic venous system in cirrhosis can predict a progression of portal hypertension.
    Hepatology. 2015 Jun 30. doi: 10.1002/hep.27967.
    PubMed     Text format    


  495. KWAN R, Chen L, Looi K, Tao GZ, et al
    PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.
    Hepatology. 2015 Jun 30. doi: 10.1002/hep.27965.
    PubMed     Text format     Abstract available


  496. HYLEMON P, Nagahashi M, Takabe K, Zhou H, et al
    Sphingosine-1-phosphate receptor 2 and conjugated bile acids: Key players in hepatic lipid metabolism.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27961.
    PubMed     Text format    


  497. CHIANG JY
    Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27964.
    PubMed     Text format    


  498. CARULLI L, Gabbi C, Bertolotti M
    Bile acids and non-alcoholic fatty liver disease: An intriguing relationship.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27963.
    PubMed     Text format    


  499. LI M, Mennone A, Soroka CJ, Hagey LR, et al
    NHERF-1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury.
    Hepatology. 2015 Jun 25. doi: 10.1002/hep.27956.
    PubMed     Text format     Abstract available


  500. BARBIER-TORRES L, Beraza N, Fernandez-Tussy P, Lopitz-Otsoa F, et al
    Histone Deacetylase 4 promotes cholestatic liver injury in the absence of Prohibitin-1.
    Hepatology. 2015 Jun 25. doi: 10.1002/hep.27959.
    PubMed     Text format     Abstract available


  501. ABERG F, Helenius-Hietala J
    Oro-hepatic link, endotoxemia, and systemic inflammation: the role of chronic periodontitis.
    Hepatology. 2015 Jun 23. doi: 10.1002/hep.27953.
    PubMed     Text format    


  502. BAJAJ JS, Zhou H, Kang DJ, Hylemon PB, et al
    Oral-Hepatic-Gut Axis: An Attractive Pill to Swallow.
    Hepatology. 2015 Jun 23. doi: 10.1002/hep.27952.
    PubMed     Text format    


  503. WU JW, Mitchell GA
    Potential mechanism underlying the PNPLA3 - hepatic steatosis connection.
    Hepatology. 2015 Jun 19. doi: 10.1002/hep.27943.
    PubMed     Text format    


  504. NIE H, Li J, Yang XM, Cao QZ, et al
    Mineralocorticoid receptor suppresses cancer progression and Warburg effect by modulating miR-338-3p-PKLR axis in hepatocellular carcinoma.
    Hepatology. 2015 Jun 16. doi: 10.1002/hep.27940.
    PubMed     Text format     Abstract available


  505. AQEL B, Pungpapong S, Leise M, Werner KT, et al
    Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis.
    Hepatology. 2015 Jun 11. doi: 10.1002/hep.27937.
    PubMed     Text format     Abstract available


  506. JIMENEZ CALVENTE C, Sehgal A, Popov Y, Kim YO, et al
    Specific hepatic delivery of procollagen alpha1(I) siRNA in lipid-like nanoparticles resolves liver fibrosis.
    Hepatology. 2015 Jun 10. doi: 10.1002/hep.27936.
    PubMed     Text format     Abstract available


  507. YANG X, Tang XP, Zhang YH, Luo KZ, et al
    Prospective evaluation of the diagnostic accuracy of hepatic copper content, As determined using the entire core of a liver biopsy sample.
    Hepatology. 2015 Jun 10. doi: 10.1002/hep.27932.
    PubMed     Text format     Abstract available


  508. LU YY, Xu W, Ji J, Feng D, et al
    Alternative splicing of the cell-fate determinant Numb in hepatocellular carcinoma.
    Hepatology. 2015 Jun 8. doi: 10.1002/hep.27923.
    PubMed     Text format     Abstract available


  509. TABIBIAN JH, O'Hara SP, Trussoni CE, Tietz PS, et al
    Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
    Hepatology. 2015 Jun 4. doi: 10.1002/hep.27927.
    PubMed     Text format     Abstract available


  510. LIANGPUNSAKUL S
    ChREBP, SIRT1 and ethanol metabolism- a complicated network in alcohol-induced hepatic steatosis.
    Hepatology. 2015 Jun 4. doi: 10.1002/hep.27926.
    PubMed     Text format    


  511. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;61:1773-5.
    PubMed     Text format    


  512. SAXENA V, Nyberg L, Pauly M, Dasgupta A, et al
    Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C Infected Patients with Compensated and Decompensated Cirrhosis.
    Hepatology. 2015 Jun 1. doi: 10.1002/hep.27922.
    PubMed     Text format     Abstract available


  513. PIND ML, Moller S, Faqir N, Bendtsen F, et al
    Predictive value of indocyanine green retention test and indocyanine green clearance in Child-Pugh class A patients.
    Hepatology. 2015;61:2112-3.
    PubMed     Text format    


  514. LISOTTI A, Azzaroli F, Mazzella G
    Reply: To PMID 24038116.
    Hepatology. 2015;61:2113-4.
    PubMed     Text format    


  515. VINCIGUERRA M
    Nitric oxide as a protector from nonalcoholic fatty liver disease.
    Hepatology. 2015;61:2115-6.
    PubMed     Text format    


  516. GU Q, Cui Z
    Reply: To PMID 25130427.
    Hepatology. 2015;61:2116.
    PubMed     Text format    


  517. MOGENSEN H, Bjornsson ES
    Varenicline-induced acute liver injury with jaundice.
    Hepatology. 2015;61:2110-1.
    PubMed     Text format    


  518. VOS MB
    Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?
    Hepatology. 2015;61:1779-80.
    PubMed     Text format    


  519. MUSSO G
    Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: all that is gold does not glitter, not all those who wander are lost.
    Hepatology. 2015;61:2104-6.
    PubMed     Text format    


  520. THAPA M, Chinnadurai R, Velazquez VM, Tedesco D, et al
    Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity.
    Hepatology. 2015;61:2067-79.
    PubMed     Text format     Abstract available


  521. SOMBETZKI M, Loebermann M, Reisinger EC
    Vector-mediated microRNA-21 silencing ameliorates granulomatous liver fibrosis in Schistosoma japonicum infection.
    Hepatology. 2015;61:1787-9.
    PubMed     Text format    


  522. LU P, Yan J, Liu K, Garbacz WG, et al
    Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21.
    Hepatology. 2015;61:1908-19.
    PubMed     Text format     Abstract available


  523. HE X, Xie J, Zhang D, Su Q, et al
    Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways.
    Hepatology. 2015;61:2008-17.
    PubMed     Text format     Abstract available


  524. KANTARI-MIMOUN C, Castells M, Klose R, Meinecke AK, et al
    Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis.
    Hepatology. 2015;61:2042-55.
    PubMed     Text format     Abstract available


    May 2015
  525. ZAMBAM DE MATTOS A, Alves de Mattos A
    Hepatocellular carcinoma - to resect or to transplant?
    Hepatology. 2015 May 29. doi: 10.1002/hep.27919.
    PubMed     Text format    


  526. SULTANIK P, Sogni P, Meritet J, Pol S, et al
    Patients with Chronic Hepatitis B should be screened for Hepatocellular Carcinoma Regardless of Liver Stiffness Measurement.
    Hepatology. 2015 May 23. doi: 10.1002/hep.27904.
    PubMed     Text format    


  527. SEYAL AR, Gonzalez-Guindalini FD, Arslanoglu A, Harmath CB, et al
    Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma.
    Hepatology. 2015 May 22. doi: 10.1002/hep.27915.
    PubMed     Text format     Abstract available


  528. WANG ZC, Gao Q, Shi JY, Guo WJ, et al
    PTPRS Acts as A Metastatic Suppressor in Hepatocellular Carcinoma by Control of EGFR Induced Epithelial-Mesenchymal Transition.
    Hepatology. 2015 May 22. doi: 10.1002/hep.27911.
    PubMed     Text format     Abstract available


  529. PATEL VC, Shawcross DL
    Salivary microbiota-immune profiling in cirrhosis: could this be the non-invasive strategy that will revolutionise prognostication in hepatology?
    Hepatology. 2015 May 22. doi: 10.1002/hep.27870.
    PubMed     Text format    


  530. KIM MN, Han KH, Kim SU
    Reply to "Patients with chronic hepatitis b should be screened for hepatocellular carcinoma regardless of liver stiffness measurement."
    Hepatology. 2015 May 20. doi: 10.1002/hep.27903.
    PubMed     Text format    


  531. LIU Z, Chen T, Wang Y, Zhang M, et al
    Age might confound the impact of the TM6SF2 E167K polymorphism on hepatic fibrosis in HCV- infected patients.
    Hepatology. 2015 May 16. doi: 10.1002/hep.27899.
    PubMed     Text format    


  532. KUMAR S
    Cholestatic Liver Injury secondary to Artemisinin.
    Hepatology. 2015 May 16. doi: 10.1002/hep.27900.
    PubMed     Text format    


  533. CUCCHETTI A, Djulbegovic B
    Response to comment on "When to Perform Hepatic Resection for Intermediate-Stage Hepatocellular Carcinoma" Hepatology. March 2015: 61(3)905-914.
    Hepatology. 2015 May 14. doi: 10.1002/hep.27897.
    PubMed     Text format    


  534. SPACEK LA, Solga SF
    When to perform hepatic resection for intermediate-stage hepatocellular carcinoma.
    Hepatology. 2015 May 14. doi: 10.1002/hep.27896.
    PubMed     Text format    


  535. YUAN SX, Wang J, Yang F, Tao QF, et al
    Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma via de-repression of CTNNB1.
    Hepatology. 2015 May 11. doi: 10.1002/hep.27893.
    PubMed     Text format     Abstract available


  536. GULDIKEN N, Zhou Q, Kucukoglu O, Rehm M, et al
    Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with JNK activation and protein adduct formation.
    Hepatology. 2015 May 11. doi: 10.1002/hep.27891.
    PubMed     Text format     Abstract available


  537. SINN DH, Lee J, Goo J, Kim K, et al
    Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.
    Hepatology. 2015 May 11. doi: 10.1002/hep.27889.
    PubMed     Text format     Abstract available


  538. OBEN JA
    Reply: To PMID 24923719.
    Hepatology. 2015;61:1766.
    PubMed     Text format    


  539. HONG HC, Choi KM
    Reply: To PMID 23996808.
    Hepatology. 2015;61:1764-5.
    PubMed     Text format    


  540. GRZELAK CA, Sigglekow ND, McCaughan GW
    GLI2 as a marker of hedgehog-responsive cells.
    Hepatology. 2015;61:1770.
    PubMed     Text format    


  541. GUY C, Suzuki A, Abdelmalek M, Burchette J, et al
    Reply: To PMID 24849310.
    Hepatology. 2015;61:1770-1.
    PubMed     Text format    


  542. LEE AS, Chen WT
    Reply: To PMID 24027047.
    Hepatology. 2015;61:1767-8.
    PubMed     Text format    


  543. RACHIDI S, Sun S, Li Z
    Endoplasmic reticulum heat shock protein gp96/grp94 is a pro-oncogenic chaperone, not a tumor suppressor.
    Hepatology. 2015;61:1766-7.
    PubMed     Text format    


  544. SOOKOIAN S, Castano GO, Pirola CJ
    PNPLA3 I148M variant is associated with metabolic stress-response phenotype in patients with nonalcoholic fatty liver disease.
    Hepatology. 2015;61:1769.
    PubMed     Text format    


  545. ZOU Z, Shen Z, Cai Y, Chen Y, et al
    The beta-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers: Is it really safe?
    Hepatology. 2015;61:1765.
    PubMed     Text format    


  546. KIM SW, Jung HW
    Which one is associated with nonalcoholic fatty liver disease? Small muscle mass or large fat mass.
    Hepatology. 2015;61:1764.
    PubMed     Text format    


  547. SONDERUP MW, Wainwright H, Hall P, Hairwadzi H, et al
    A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome.
    Hepatology. 2015;61:1721-9.
    PubMed     Text format     Abstract available


  548. CAI JB, Shi GM, Dong ZR, Ke AW, et al
    Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression.
    Hepatology. 2015;61:1603-14.
    PubMed     Text format     Abstract available


  549. CHEN Y, Ramjiawan RR, Reiberger T, Ng MR, et al
    CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
    Hepatology. 2015;61:1591-602.
    PubMed     Text format     Abstract available


  550. ADAMS LA, Crawford DH, Stuart K, House MJ, et al
    The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial.
    Hepatology. 2015;61:1555-64.
    PubMed     Text format     Abstract available


  551. EKSTEDT M, Hagstrom H, Nasr P, Fredrikson M, et al
    Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
    Hepatology. 2015;61:1547-54.
    PubMed     Text format     Abstract available


  552. TORRES DM, Harrison SA
    Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
    Hepatology. 2015;61:1462-4.
    PubMed     Text format    


    April 2015
  553. BANTEL H, Thum T, Schulze-Osthoff K
    Reply.
    Hepatology. 2015;61:1440-1.
    PubMed     Text format    


  554. SCHRAMM C, Wahl I, Lohse AW
    Reply.
    Hepatology. 2015;61:1435.
    PubMed     Text format    


  555. ANTOINE DJ, Dear JW, Goldring CE, Park BK, et al
    Understanding the pathophysiological regulatory role of microRNAs in acute liver failure.
    Hepatology. 2015;61:1439-40.
    PubMed     Text format    


  556. SCHILSKY ML, Roberts EA, Hahn S, Askari F, et al
    Costly choices for treating Wilson's disease.
    Hepatology. 2015;61:1106-8.
    PubMed     Text format    


  557. MARICIC I, Sheng H, Marrero I, Seki E, et al
    Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
    Hepatology. 2015;61:1357-69.
    PubMed     Text format     Abstract available


  558. MARAS JS, Maiwall R, Harsha HC, Das S, et al
    Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure.
    Hepatology. 2015;61:1306-20.
    PubMed     Text format     Abstract available


  559. METUSHI IG, Hayes MA, Uetrecht J
    Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients.
    Hepatology. 2015;61:1332-42.
    PubMed     Text format     Abstract available


  560. OH S, Shida T, Yamagishi K, Tanaka K, et al
    Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study.
    Hepatology. 2015;61:1205-15.
    PubMed     Text format     Abstract available


  561. JOPHLIN LL, Koch DG
    Takotsubo cardiomyopathy following acute liver failure.
    Hepatology. 2015;61:1430-1.
    PubMed     Text format    


    February 2015
  562. GHONEM NS, Assis DN, Boyer JL
    On fibrates and cholestasis: A review.
    Hepatology. 2015 Feb 11. doi: 10.1002/hep.27744.
    PubMed     Text format     Abstract available


    January 2015
  563. POUPON R
    Liver alkaline phosphatase: A missing link between choleresis and biliary inflammation.
    Hepatology. 2015 Jan 20. doi: 10.1002/hep.27715.
    PubMed     Text format     Abstract available


    December 2014
  564. FOUASSIER L, Fiorotto R
    Ezrin finds its groove in cholangiocytes.
    Hepatology. 2014 Dec 24. doi: 10.1002/hep.27675.
    PubMed     Text format    


    October 2014
  565. NAVARRO VJ, Barnhart H, Bonkovsky HL, Davern T, et al
    Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
    Hepatology. 2014;60:1399-408.
    PubMed     Text format     Abstract available


  566. SCORLETTI E, Bhatia L, McCormick KG, Clough GF, et al
    Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
    Hepatology. 2014;60:1211-21.
    PubMed     Text format     Abstract available


  567. MCGILL MR, Staggs VS, Sharpe MR, Lee WM, et al
    Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome.
    Hepatology. 2014;60:1336-45.
    PubMed     Text format     Abstract available


  568. JOHN K, Hadem J, Krech T, Wahl K, et al
    MicroRNAs play a role in spontaneous recovery from acute liver failure.
    Hepatology. 2014;60:1346-55.
    PubMed     Text format     Abstract available


  569. COLOMBO M, Sangiovanni A
    Vitamin D deficiency and liver cancer: more than just an epidemiological association?
    Hepatology. 2014;60:1130-2.
    PubMed     Text format    


  570. KOUNTOURAS J, Polyzos SA, Zavos C, Deretzi G, et al
    Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors.
    Hepatology. 2014;60:1450-1.
    PubMed     Text format    


  571. VERRIJKEN A, Francque S, Mertens I, Gaal LV, et al
    Reply: To PMID 24375485.
    Hepatology. 2014;60:1451.
    PubMed     Text format    


  572. GRIFFITH LG, Wells A, Stolz DB
    Engineering liver.
    Hepatology. 2014;60:1426-34.
    PubMed     Text format     Abstract available


  573. MANN DA
    Epigenetics in liver disease.
    Hepatology. 2014;60:1418-25.
    PubMed     Text format     Abstract available


  574. CHEN RP, Chen C, Yu JY, Huang XL, et al
    Trial sequence meta-analysis can reject false-positive result calculated from conventional meta-analysis.
    Hepatology. 2014;60:1442-3.
    PubMed     Text format    


  575. BERNARDI M, Caraceni P, Navickis RJ, Wilkes MM, et al
    Reply: To PMID 22095893.
    Hepatology. 2014;60:1443-5.
    PubMed     Text format    


  576. VINCIGUERRA M
    Normalization of a NAFLD gene expression signature.
    Hepatology. 2014;60:1445.
    PubMed     Text format    


  577. MOYLAN CA, Pang H, Michelotti G, Diehl AM, et al
    Reply: To PMID 23913408.
    Hepatology. 2014;60:1445-6.
    PubMed     Text format    


    August 2014
  578. SLAGLE BL, Andrisani OM, Bouchard MJ, Lee CG, et al
    Technical standards for hepatitis B virus X protein (HBx) research.
    Hepatology. 2014 Aug 7. doi: 10.1002/hep.27360.
    PubMed     Text format     Abstract available


    May 2014
  579. LLEO A, Zhang W, McDonald WH, Seeley EH, et al
    Shotgun Proteomics: Identification of Unique Protein Profiles of Apoptotic Bodies from Biliary Epithelial Cells.
    Hepatology. 2014 May 20. doi: 10.1002/hep.27230.
    PubMed     Text format     Abstract available


    February 2014
  580. RODRIGO-TORRES D, Affo S, Coll M, Morales-Ibanez O, et al
    The biliary epithelium gives rise to liver progenitor cells.
    Hepatology. 2014 Feb 20. doi: 10.1002/hep.27078.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: